2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
Tóm tắt
Từ khóa
Tài liệu tham khảo
Smith, 2006, AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute, J Am Coll Cardiol, 47, 2130, 10.1016/j.jacc.2006.04.026
Gibbons
Rosamond, 2007, Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 115, e69, 10.1161/CIRCULATIONAHA.106.179918
1993
Libby, 2001, Current concepts of the pathogenesis of the acute coronary syndromes, Circulation, 104, 365, 10.1161/01.CIR.104.3.365
Hamm, 2001, Acute coronary syndrome without ST elevation: implementation of new guidelines, Lancet, 358, 1533, 10.1016/S0140-6736(01)06585-0
Davies, 2000, The pathophysiology of acute coronary syndromes, Heart, 83, 361, 10.1136/heart.83.3.361
Wu, 1999, National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases, Clin Chem, 45, 1104, 10.1093/clinchem/45.7.1104
Braunwald, 1998, Unstable angina: an etiologic approach to management, Circulation, 98, 2219, 10.1161/01.CIR.98.21.2219
DeWood, 1986, Coronary arteriographic findings soon after non-Q-wave myocardial infarction, N Engl J Med, 315, 417, 10.1056/NEJM198608143150703
Grundy, 2004, Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines, Circulation, 110, 227, 10.1161/01.CIR.0000133317.49796.0E
2002, Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on DetectionEvaluationand Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report, Circulation, 106, 3143, 10.1161/circ.106.25.3143
2001, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on DetectionEvaluationAnd Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486
Lloyd-Jones, 2006, Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age, Circulation, 113, 791, 10.1161/CIRCULATIONAHA.105.548206
Ebrahim, 2000, Multiple risk factor interventions for primary prevention of coronary heart disease, Cochrane Database Syst Rev
Ross, 1999, Clinical outcomes in statin treatment trials: a meta-analysis, Arch Intern Med, 159, 1793, 10.1001/archinte.159.15.1793
Grundy, 1999, Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology, Circulation, 100, 1481, 10.1161/01.CIR.100.13.1481
Pearson, 2002, AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Dis-eases, Circulation, 106, 388, 10.1161/01.CIR.0000020190.45892.75
Wilson, 2000, Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies, Arch Intern Med, 160, 939, 10.1001/archinte.160.7.939
Freemantle, 1999, Blockade after myocardial infarction: systematic review and meta regression analysis, BMJ, 318, 1730, 10.1136/bmj.318.7200.1730
Mosca, 2004, Cardiology patient page. Heart disease prevention in women. American Heart Association, Circulation, 109, e158
Teo, 2006, Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study, Lancet, 368, 647, 10.1016/S0140-6736(06)69249-0
Tonstad, 2006, Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial, JAMA, 296, 64, 10.1001/jama.296.1.64
Jorenby, 2006, Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial, JAMA, 296, 56, 10.1001/jama.296.1.56
Gonzales, 2006, Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial, JAMA, 296, 47, 10.1001/jama.296.1.47
Ranney, 2006, Systematic review: smoking cessation intervention strategies for adults and adults in special populations, Ann Intern Med, 145, 845, 10.7326/0003-4819-145-11-200612050-00142
2006, National Institutes of Health state-of-the-science conference statement: tobacco use: prevention, cessation, and control, Ann Intern Med, 145, 839, 10.7326/0003-4819-145-11-200612050-00141
Mosca, 2007, Evidence-based guidelines for cardiovascular disease prevention in women, J Am Coll Cardiol, 49, 1230, 10.1016/j.jacc.2007.02.020
Brown, 2004, New guidelines for low-density lipoprotein levels from the National Cholesterol Education Program (NCEP): a 2004 update, Prog Cardiovasc Nurs, 19, 165, 10.1111/j.0889-7204.2003.02910.x
1998, Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—The Evidence Report, Obes Res, 6, 51S
Chobanian, 2003, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report, JAMA, 289, 2560, 10.1001/jama.289.19.2560
Pignone, 2001, Evidence based management of hypertension:Using cardiovascular risk profiles to individualise hypertensive treatment, BMJ, 322, 1164, 10.1136/bmj.322.7295.1164
Lichtenstein, 2006, Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee, Circulation, 114, 82, 10.1161/CIRCULATIONAHA.106.176158
Turnbull, 2003, Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials, Lancet, 362, 1527, 10.1016/S0140-6736(03)14739-3
1991, Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension, JAMA, 265, 3255, 10.1001/jama.1991.03460240051027
Grundy, 2002, Prevention Conference VI: Diabetes and Cardiovascular Disease:executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association, Circulation, 105, 2231, 10.1161/01.CIR.0000013952.86046.DD
Eckel, 2006, Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association, Circulation, 113, 2943, 10.1161/CIRCULATIONAHA.106.176583
Hayden, 2002, Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force, Ann Intern Med, 136, 161, 10.7326/0003-4819-136-2-200201150-00016
2002, Aspirin for the primary prevention of cardiovascular events: recommendation and rationale, Ann Intern Med, 136, 157, 10.7326/0003-4819-136-2-200201150-00015
Peters, 2003, Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study, Circulation, 108, 1682, 10.1161/01.CIR.0000091201.39590.CB
Hung, 2003, Aspirin for cardiovascular disease prevention, Med J Aust, 179, 147, 10.5694/j.1326-5377.2003.tb05474.x
Abidov, 2005, Prognostic significance of dyspnea in patients referred for cardiac stress testing, N Engl J Med, 353, 1889, 10.1056/NEJMoa042741
Goff, 1998, Knowledge of heart attack symptoms in a population survey in the United States: the REACT Trial, Arch Intern Med, 158, 2329, 10.1001/archinte.158.21.2329
Goff, 1999, Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT trial, Am Heart J, 138, 1046, 10.1016/S0002-8703(99)70069-4
Rogers, 2000, Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3, J Am Coll Cardiol, 36, 2056, 10.1016/S0735-1097(00)00996-7
Welsh, 2003, Prehospital management of acute ST-elevation myocardial infarction: a time for reappraisal in North America, Am Heart J, 145, 1, 10.1067/mhj.2003.47
Goldberg, 2002, Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry), Am J Cardiol, 89, 791, 10.1016/S0002-9149(02)02186-0
Finnegan, 2000, Patient delay in seeking care for heart attack symptoms: findings from focus groups conducted in five U.S. regions, Prev Med, 31, 205, 10.1006/pmed.2000.0702
Luepker, 2000, Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: the Rapid Early Action for Coronary Treatment (REACT) trial, JAMA, 284, 60, 10.1001/jama.284.1.60
Feldman, 1998, Statistical design of REACT (Rapid Early Action for Coronary Treatment), a multisite community trial with continual data collection, Control Clin Trials, 19, 391, 10.1016/S0197-2456(98)00014-2
Leslie, 2000, Delay in calling for help during myocardial infarction: reasons for the delay and subsequent pattern of accessing care, Heart, 84, 137, 10.1136/heart.84.2.137
McKinley, 2000, Treatment-seeking behavior for acute myocardial infarction symptoms in North America and Australia, Heart Lung, 29, 237, 10.1067/mhl.2000.106940
Rucker, 2001, Delay in seeking emergency care, Acad Emerg Med, 8, 163, 10.1111/j.1553-2712.2001.tb01282.x
Deleted in proof.
Moser, 2006, Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on cardiovascular nursing and stroke council, Circulation, 114, 168, 10.1161/CIRCULATIONAHA.106.176040
Sheifer, 2000, Prevalence, predisposing factors, and prognosis of clinically unrecognized myocardial infarction in the elderly, J Am Coll Cardiol, 35, 119, 10.1016/S0735-1097(99)00524-0
Kannel, 1986, Silent myocardial ischemia and infarction: insights from the Framingham Study, Cardiol Clin, 4, 583, 10.1016/S0733-8651(18)30577-0
Canto, 2000, Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain, JAMA, 283, 3223, 10.1001/jama.283.24.3223
Rathore, 2001, Treatment of patients with myocardial infarction who present with a paced rhythm, Ann Intern Med, 134, 644, 10.7326/0003-4819-134-8-200104170-00009
Dracup, 1997, The physician's role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program, Ann Intern Med, 126, 645, 10.7326/0003-4819-126-8-199704150-00010
Selker, 1998, Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia: a multicenter, controlled clinical trial, Ann Intern Med, 129, 845, 10.7326/0003-4819-129-11_Part_1-199812010-00002
Faxon, 2001, Timing is everything: motivating patients to call 9–1–1 at onset of acute myocardial infarction, Circulation, 104, 1210, 10.1161/circ.104.11.1210
Ghali, 1993, Delay between onset of chest pain and arrival to the coronary care unit among minority and disadvantaged patients, J Natl Med Assoc, 85, 180
Hargarten, 1990, Prehospital prophylactic lidocaine does not favorably affect outcome in patients with chest pain, Ann Emerg Med, 19, 1274, 10.1016/S0196-0644(05)82287-5
Tatum, 1997, Comprehensive strategy for the evaluation and triage of the chest pain patient, Ann Emerg Med, 29, 116, 10.1016/S0196-0644(97)70317-2
Tatum, 1997, Cost effective nuclear scanning in a comprehensive and systematic approach to the evaluation of chest pain in the emergency department, Md Med J, 25
Ornato, 1999, Chest pain emergency centers: improving acute myocardial infarction care, Clin Cardiol, 22, IV3, 10.1002/clc.4960221603
Newby, 2001, Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study, Circulation, 103, 1832, 10.1161/01.CIR.103.14.1832
Lateef, 2001, Heart emergency room: effective for both geriatric and younger patients, Singapore Med J, 42, 259
Lateef, 2001, Comparison of a 6-hour and 9-hour protocol for evaluation of moderate-to-low risk chest pain patients in an emergency department diagnostic unit, Singapore Med J, 42, 52
Gibler, 1994, Chest pain evaluation in the ED: beyond triage, Am J Emerg Med, 12, 121, 10.1016/0735-6757(94)90219-4
Gibler, 1995, Evaluation of chest pain in the emergency department, Ann Intern Med, 123, 315, 10.7326/0003-4819-123-4-199508150-00016
Gibler, 1997, Chest pain units: do they make sense now?, Ann Emerg Med, 29, 168
Gibler, 1994, Evaluating patients with chest pain in the ED: improving speed, efficiency, and cost-effectiveness, or teaching an old dog new tricks, Ann Emerg Med, 23, 381, 10.1016/S0196-0644(94)90002-7
Hoekstra, 1994, Emergency-department diagnosis of acute myocardial infarction and ischemia: a cost analysis of two diagnostic protocols, Acad Emerg Med, 1, 103, 10.1111/j.1553-2712.1994.tb02731.x
Hoekstra, 1994, Emergency department CK-MB: a predictor of ischemic complications, Acad Emerg Med, 1, 17, 10.1111/j.1553-2712.1994.tb02795.x
Cannon, 2002, Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program, Am Heart J, 143, 777, 10.1067/mhj.2002.120260
Zalenski, 2000, National Heart Attack Alert Program position paper: chest pain centers and programs for the evaluation of acute cardiac ischemia, Ann Emerg Med, 35, 462, 10.1016/S0196-0644(00)70007-2
Lambrew, 1996, Hospital protocols and policies that may delay early identification and thrombolytic therapy of acute myocardial infarction patients, J Thromb Thrombolysis, 3, 301, 10.1007/BF00133073
Farkouh, 1998, A clinical trial of a chest-pain observation unit for patients with unstable angina, N Engl J Med, 339, 1882, 10.1056/NEJM199812243392603
Hedges, 2000, Impact of community intervention to reduce patient delay time on use of reperfusion therapy for acute myocardial infarction: rapid early action for coronary treatment (REACT) trial, Acad Emerg Med, 7, 862, 10.1111/j.1553-2712.2000.tb02063.x
Canto, 2002, Use of emergency medical services in acute myocardial infarction and subsequent quality of care: observations from the National Registry of Myocardial Infarction 2, Circulation, 106, 3018, 10.1161/01.CIR.0000041246.20352.03
Goldberg, 2000, Age and sex differences in presentation of symptoms among patients with acute coronary disease: the REACT Trial, Coron Artery Dis, 11, 399, 10.1097/00019501-200007000-00004
Hutchings, 2004, Patients with chest pain calling 9-1-1 or self-transporting to reach definitive care: which mode is quicker?, Am Heart J, 147, 35, 10.1016/S0002-8703(03)00510-6
Becker, 1996, Incidence of cardiac arrest during self-transport for chest pain, Ann Emerg Med, 18, 612, 10.1016/S0196-0644(96)70082-3
Brown, 2000, Demographic, belief, and situational factors influencing the decision to utilize emergency medical services among chest pain patients, Circulation, 102, 173, 10.1161/01.CIR.102.2.173
Herlitz, 1992, Early identification of acute myocardial infarction and prognosis in relation to mode of transport to hospital, Am J Emerg Med, 10, 406, 10.1016/0735-6757(92)90064-5
Ho, 1989, Delay between onset of chest pain and seeking medical care: the effect of public education, Ann Emerg Med, 18, 727, 10.1016/S0196-0644(89)80004-6
Dracup, 1995, Causes of delay in seeking treatment for heart attack symptoms, Soc Sci Med, 40, 379, 10.1016/0277-9536(94)00278-2
Herlitz, 1992, Follow-up of a 1-year media campaign on delay times and ambulance use in suspected acute myocardial infarction, Eur Heart J, 13, 171, 10.1093/oxfordjournals.eurheartj.a060142
Wright, 2001, Impact of communitybased education on health care evaluation in patients with acute chest pain syndromes: the Wabasha Heart Attack Team (WHAT) project, Fam Pract, 18, 537, 10.1093/fampra/18.5.537
Hand, 1998, Access to timely and optimal care of patients with acute coronary syndromes—community planning considerations: a report by the National Heart Attack Alert Program, J Thromb Thrombolysis, 6, 19, 10.1023/A:1008820104852
Simon, 1972, Components of delay in the pre-hospital phase of acute myocardial infarction, Am J Cardiol, 30, 476, 10.1016/0002-9149(72)90037-9
Ryan
Alonzo, 1986, The impact of the family and lay others on care-seeking during life-threatening episodes of suspected coronary artery disease, Soc Sci Med, 22, 1297, 10.1016/0277-9536(86)90093-6
2000, Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care, Circulation, 102, I172
McDermott, 2003, Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease, Arch Intern Med, 163, 2157, 10.1001/archinte.163.18.2157
Newby, 1996, Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial, J Am Coll Cardiol, 27, 625, 10.1016/0735-1097(95)00513-7
Maynard, 1995, Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the National Registry of Myocardial Infarction), Am J Cardiol, 76, 548, 10.1016/S0002-9149(99)80152-0
Weaver, 1993, Prehospitalinitiated vs hospital-initiated thrombolytic therapy: the Myocardial Infarction Triage and Intervention Trial, JAMA, 270, 1211, 10.1001/jama.1993.03510100061033
Braunwald, 1994
Pope, 1998, Clinical features of emergency department patients presenting with symptoms suggestive of acute cardiac ischemia: a multicenter study, J Thromb Thrombolysis, 6, 63, 10.1023/A:1008876322599
Theroux, 1998, Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction, Circulation, 97, 1195, 10.1161/01.CIR.97.12.1195
Savonitto, 1999, Prognostic value of the admission electrocardiogram in acute coronary syndromes, JAMA, 281, 707, 10.1001/jama.281.8.707
1998, Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes, N Engl J Med, 339, 436, 10.1056/NEJM199808133390704
1994, Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB Trial, Circulation, 89, 1545, 10.1161/01.CIR.89.4.1545
1998, Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction, N Engl J Med, 338, 1488, 10.1056/NEJM199805213382102
Chang, 2004, Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT, Am Heart J, 148, 62, 10.1016/j.ahj.2003.05.004
Ronner, 2002, Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization:an analysis of the PURSUIT trial, J Am Coll Cardiol, 39, 1924, 10.1016/S0735-1097(02)01897-1
Zhao, 1999, Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction: angiographic results from the PRISM-PLUS trial, Circulation, 100, 1609, 10.1161/01.CIR.100.15.1609
Chaitman, 1981, Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS), Circulation, 64, 360, 10.1161/01.CIR.64.2.360
Pryor, 1983, Estimating the likelihood of significant coronary artery disease, Am J Med, 75, 771, 10.1016/0002-9343(83)90406-0
Pryor, 1993, Value of the history and physical in identifying patients at increased risk for coronary artery disease, Ann Intern Med, 118, 81, 10.7326/0003-4819-118-2-199301150-00001
Morise, 1997, Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease, Am J Med, 102, 350, 10.1016/S0002-9343(97)00086-7
Ho, 2002, Use of a simple clinical score to predict prognosis of patients with normal or mildly abnormal resting electrocardiographic findings undergoing evaluation for coronary artery disease, Mayo Clin Proc, 77, 515, 10.4065/77.6.515
Kasser, 1969, Comparative effects of aging and coronary heart disease on submaximal and maximal exercise, Circulation, 39, 759, 10.1161/01.CIR.39.6.759
Patel, 2004, Symptoms in acute coronary syndromes: does sex make a difference?, Am Heart J, 148, 27, 10.1016/j.ahj.2004.03.005
McSweeney, 2003, Women's early warning symptoms of acute myocardial infarction, Circulation, 108, 2619, 10.1161/01.CIR.0000097116.29625.7C
Lee, 1985, Acute chest pain in the emergency room: identification and examination of low-risk patients, Arch Intern Med, 145, 65, 10.1001/archinte.1985.00360010085013
Pozen, 1984, A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease: a prospective multicenter clinical trial, N Engl J Med, 310, 1273, 10.1056/NEJM198405173102001
Selker, 1991, A tool for judging coronary care unit admission appropriateness, valid for both real-time and retrospective use, Med Care, 29, 610, 10.1097/00005650-199107000-00002
Henrikson, 2003, Chest pain relief by nitroglycerin does not predict active coronary artery disease, Ann Intern Med, 139, 979, 10.7326/0003-4819-139-12-200312160-00007
Swap, 2005, Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes, JAMA, 294, 2623, 10.1001/jama.294.20.2623
Brieger, 1998, Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial): Global Utilization of Streptokinase and TPA for occluded arteries, Am J Cardiol, 81, 282, 10.1016/S0002-9149(97)00909-0
Hochman, 1999, Sex, clinical presentation, and outcome in patients with acute coronary syndromes, N Engl J Med, 341, 226, 10.1056/NEJM199907223410402
Hochman, 1997, Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction, J Am Coll Cardiol, 30, 141, 10.1016/S0735-1097(97)00107-1
Scirica, 1999, Differences between men and women in the management of unstable angina pectoris (the GUARANTEE registry), Am J Cardiol, 84, 1145, 10.1016/S0002-9149(99)00525-1
Holmes, 1999, Effect of age on outcome with primary angioplasty versus thrombolysis, J Am Coll Cardiol, 33, 412, 10.1016/S0735-1097(98)00579-8
White, 1996, Age and outcome with contemporary thrombolytic therapy: results from the GUSTO-I trial, Circulation, 94, 1826, 10.1161/01.CIR.94.8.1826
Jayes, 1992, Do patients' coronary risk factor reports predict acute cardiac ischemia in the emergency department?, J Clin Epidemiol, 45, 621, 10.1016/0895-4356(92)90134-9
Michos, 2005, Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis, Am Heart J, 150, 1276, 10.1016/j.ahj.2005.02.037
Tadros, 2003, Clinical predictors of 30-day cardiac events in patients with acute coronary syndrome at a community hospital, South Med J, 96, 1113, 10.1097/01.SMJ.0000053481.49309.58
Nasir, 2004, Coronary artery calcification and family history of premature coronary heart disease: sibling history is more strongly associated than parental history, Circulation, 110, 2150, 10.1161/01.CIR.0000144464.11080.14
Mak, 1997, Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries, J Am Coll Cardiol, 30, 171, 10.1016/S0735-1097(97)00118-6
Antman, 2000, The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making, JAMA, 284, 835, 10.1001/jama.284.7.835
Mehta, 2006, The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction, Eur Heart J, 28, 415, 10.1093/eurheartj/ehl329
Nigam, 2006, Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent reinfarction and cardiac death, Int J Cardiol, 110, 153, 10.1016/j.ijcard.2005.06.040
Rubinshtein, 2006, Relation between obesity and severity of coronary artery disease in patients undergoing coronary angiography, Am J Cardiol, 97, 1277, 10.1016/j.amjcard.2005.11.061
Jee, 2006, Body-mass index and mortality in Korean men and women, N Engl J Med, 355, 779, 10.1056/NEJMoa054017
Adams, 2006, Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old, N Engl J Med, 355, 763, 10.1056/NEJMoa055643
Romero-Corral, 2006, Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies, Lancet, 368, 666, 10.1016/S0140-6736(06)69251-9
Mittleman, 1999, Triggering of myocardial infarction by cocaine, Circulation, 99, 2737, 10.1161/01.CIR.99.21.2737
Eagle, 2004, A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry, JAMA, 291, 2727, 10.1001/jama.291.22.2727
Cohen, 1997, A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease, N Engl J Med, 337, 447, 10.1056/NEJM199708143370702
Pollack, 2006, Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population, Acad Emerg Med, 23, 13, 10.1197/j.aem.2005.06.031
Morrow, 2001, A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy, Lancet, 358, 1571, 10.1016/S0140-6736(01)06649-1
Boersma, 2000, Predictors of outcome in patients with acute coronary syndromes without persistent STsegment elevation, Circulation, 101, 2557, 10.1161/01.CIR.101.22.2557
Granger, 2003, Predictors of hospital mortality in the global registry of acute coronary events, Arch Intern Med, 163, 2345, 10.1001/archinte.163.19.2345
Giugliano, 2005, The year in non-ST-segment elevation acute coronary syndromes, J Am Coll Cardiol, 46, 906, 10.1016/j.jacc.2005.06.051
Selker, 1997, An evaluation of technologies for identifying acute cardiac ischemia in the emergency department: a report from a National Heart Attack Alert Program Working Group, Ann Emerg Med, 29, 13, 10.1016/S0196-0644(97)70298-1
Savonitto, 2005, Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes, Eur Heart J, 26, 2106, 10.1093/eurheartj/ehi395
Chang, 2006, Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction, Eur Heart J, 27, 419, 10.1093/eurheartj/ehi700
Das, 2006, Increased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertro-phy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insufficiency, Cardiol Rev, 14, 14, 10.1097/01.crd.0000148162.88296.9f
Coca, 2006, Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease, JAMA, 296, 1377, 10.1001/jama.296.11.1377
Antman, 1999, Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Qwave myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) 11B trial, Circulation, 100, 1593, 10.1161/01.CIR.100.15.1593
Morrow, 2002, An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes, Eur Heart J, 23, 223, 10.1053/euhj.2001.2738
Cannon, 2001, Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban, N Engl J Med, 344, 1879, 10.1056/NEJM200106213442501
Zaacks, 1999, Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications?, J Am Coll Cardiol, 33, 107, 10.1016/S0735-1097(98)00553-1
Rouan, 1989, Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study), Am J Cardiol, 64, 1087, 10.1016/0002-9149(89)90857-6
Lee, 1990, Impact of the availability of a prior electrocardiogram on the triage of the patient with acute chest pain, J Gen Intern Med, 5, 381, 10.1007/BF02599421
Adams, 1993, Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990s?, Circulation, 88, 750, 10.1161/01.CIR.88.2.750
Matetzky, 1999, Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7–9: “hidden” ST-segment elevations revealing acute posterior infarction, J Am Coll Cardiol, 34, 748, 10.1016/S0735-1097(99)00249-1
Boden, 1987, Electrocardiographic evolution of posterior acute myocardial infarction: importance of early precordial ST-segment depression, Am J Cardiol, 59, 782, 10.1016/0002-9149(87)91091-5
Zalenski, 1997, Value of posterior and right ventricular leads in comparison to the standard 12-lead electrocardiogram in evaluation of ST-segment elevation in suspected acute myocardial infarction, Am J Cardiol, 79, 1579, 10.1016/S0002-9149(97)00202-6
de Zwaan, 1989, Angiographic and clinical characteristics of patients with unstable angina showing an ECG pattern indicating critical narrowing of the proximal LAD coronary artery, Am Heart J, 117, 657, 10.1016/0002-8703(89)90742-4
Haines, 1983, Anatomic and prognostic significance of new T-wave inversion in unstable angina, Am J Cardiol, 52, 14, 10.1016/0002-9149(83)90061-9
Renkin, 1990, Reversal of segmental hypokinesis by coronary angioplasty in patients with unstable angina, persistent T wave inversion, and left anterior descending coronary artery stenosis, Circulation, 82, 913, 10.1161/01.CIR.82.3.913
McCarthy, 1990, Detecting acute cardiac ischemia in the emergency department: a review of the literature, J Gen Intern Med, 5, 365, 10.1007/BF02600409
Slater, 1987, Outcome in suspected acute myocardial infarction with normal or minimally abnormal admission electrocardiographic findings, Am J Cardiol, 60, 766, 10.1016/0002-9149(87)91020-4
Agarwal, 1999, Importance of posterior chest leads in patients with suspected myocardial infarction, but nondiagnostic, routine 12-lead electrocardiogram, Am J Cardiol, 83, 323, 10.1016/S0002-9149(98)00861-3
Zalenski, 1998, ST segment elevation and the prediction of hospital life-threatening complications: the role of right ventricular and posterior leads, J Electrocardiol, 3, 164, 10.1016/S0022-0736(98)90311-9
Matetzky, 1998, Significance of ST segment elevations in posterior chest leads (V7 to V9) in patients with acute inferior myocardial infarction: application for thrombolytic therapy, J Am Coll Cardiol, 31, 506, 10.1016/S0735-1097(97)00538-X
Cannon, 1997, The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study, J Am Coll Cardiol, 30, 133, 10.1016/S0735-1097(97)00160-5
Ohman, 1996, Cardiac troponin T levels for risk stratification in acute myocardial ischemia, N Engl J Med, 335, 1333, 10.1056/NEJM199610313351801
Antman, 1996, Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes, N Engl J Med, 335, 1342, 10.1056/NEJM199610313351802
Hyde, 1999, Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression, Am J Cardiol, 84, 379, 10.1016/S0002-9149(99)00319-7
Lloyd-Jones, 1998, Electrocardiographic and clinical predictors of acute myocardial infarction in patients with unstable angina pectoris, Am J Cardiol, 81, 1182, 10.1016/S0002-9149(98)00155-6
Brush, 1985, Use of the initial electrocardiogram to predict in-hospital complications of acute myocardial infarction, N Engl J Med, 312, 1137, 10.1056/NEJM198505023121801
Fesmire, 1989, Risk stratification according to the initial electrocardiogram in patients with suspected acute myocardial infarction, Arch Intern Med, 849, 1294, 10.1001/archinte.1989.00390060044009
Fesmire, 1991, Diagnostic and prognostic importance of comparing the initial to the previous electrocardiogram in patients admitted for suspected acute myocardial infarction, South Med J, 84, 841, 10.1097/00007611-199107000-00006
Fesmire, 1995, Instability of ST segments in the early stages of acute myocardial infarction in patients undergoing continuous 12-lead ECG monitoring, Am J Emerg Med, 13, 158, 10.1016/0735-6757(95)90084-5
Fesmire, 1998, Usefulness of automated serial 12-lead ECG monitoring during the initial emergency department evaluation of patients with chest pain, Ann Emerg Med, 31, 3, 10.1016/S0196-0644(98)70274-4
Kudenchuk, 1998, Utility of the prehospital electrocardiogram in diagnosing acute coronary syndromes: the Myocardial Infarction Triage and Intervention (MITI) project, J Am Coll Cardiol, 32, 17, 10.1016/S0735-1097(98)00175-2
Langer, 1989, ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome, J Am Coll Cardiol, 13, 1495, 10.1016/0735-1097(89)90338-0
Langer, 1990, Relation of angiographic detected intracoronary thrombus and silent myocardial ischemia in unstable angina pectoris, Am J Cardiol, 66, 1381, 10.1016/0002-9149(90)91175-6
Fesmire, 2000, Delta CK-MB outperforms delta troponin I at 2 hours during the ED rule out of acute myocardial infarction, Am J Emerg Med, 18, 1, 10.1016/S0735-6757(00)90038-X
Hedges, 1992, Serial ECGs are less accurate than serial CK-MB results for emergency department diagnosis of myocardial infarction, Ann Emerg Med, 21, 1445, 10.1016/S0196-0644(05)80057-5
Fesmire, 2002, The Erlanger chest pain evaluation protocol: a one-year experience with serial 12-lead ECG monitoring, two-hour delta serum marker measurements, and selective nuclear stress testing to identify and exclude acute coronary syndromes, Ann Emerg Med, 40, 584, 10.1067/mem.2002.129506
Patel, 1996, Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram, Heart, 75, 222, 10.1136/hrt.75.3.222
Patel, 1998, Long-term prognosis in unstable angina: the importance of early risk stratification using continuous ST segment monitoring, Eur Heart J, 19, 240, 10.1053/euhj.1997.0586
Hochman, 1999, SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK: an international randomized trial of emergency PTCA/CABG-trial design, Am Heart J, 137, 313, 10.1053/hj.1999.v137.95352
Holmes, 1999, Cardiogenic shock in patients with acute ischemic syndromes with and without STsegment elevation, Circulation, 100, 2067, 10.1161/01.CIR.100.20.2067
Alpert, 2000, Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction, J Am Coll Cardiol, 36, 959, 10.1016/S0735-1097(00)00804-4
Shapiro, 2007, Cardiac biomarkers, 773
Tsung, 1981, Several conditions causing elevation of serum CK-MB and CK-BB, Am J Clin Pathol, 75, 711, 10.1093/ajcp/75.5.711
Christenson, 1999, Standardization of creatine kinase-MB (CK-MB) mass assays: the use of recombinant CK-MB as a reference material, Clin Chem, 45, 1414, 10.1093/clinchem/45.9.1414
Mair, 1995, Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction, Clin Chem, 41, 1266, 10.1093/clinchem/41.9.1266
Jaffe, 2006, Biomarkers in acute cardiac disease:the present and the future, J Am Coll Cardiol, 48, 1, 10.1016/j.jacc.2006.02.056
James, 2004, A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes, Int J Cardiol, 93, 113, 10.1016/S0167-5273(03)00157-8
Panteghini, 2004, Evaluation of imprecision for cardiac troponin assays at low-range concentrations, Clin Chem, 50, 327, 10.1373/clinchem.2003.026815
Freda, 2002, Cardiac troponins in renal insufficiency: review and clinical implications, J Am Coll Cardiol, 40, 2065, 10.1016/S0735-1097(02)02608-6
Roger, 2006, Redefinition of myocardial infarction: prospective evaluation in the community, Circulation, 114, 790, 10.1161/CIRCULATIONAHA.106.627505
Hamm, 1997, Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I, N Engl J Med, 337, 1648, 10.1056/NEJM199712043372302
Galvani, 1997, Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina, Circulation, 95, 2053, 10.1161/01.CIR.95.8.2053
Lindahl, 1997, Risk stratification in unstable coronary artery disease: additive value of troponin T determinations and pre-discharge exercise tests, Eur Heart J, 18, 762, 10.1093/oxfordjournals.eurheartj.a015341
Heidenreich, 2000, Prediction of risk for patients with unstable angina, Evid Rep Technol Assess (Summ), 1
Aviles, 2002, Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction, N Engl J Med, 346, 2047, 10.1056/NEJMoa013456
Wanner, 2005, Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis, N Engl J Med, 353, 238, 10.1056/NEJMoa043545
Dragu, 2006, Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction?, Am J Cardiol, 97, 1142, 10.1016/j.amjcard.2005.11.028
Han, 2006, Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes, Am J Med, 119, 248, 10.1016/j.amjmed.2005.08.057
Masoudi, 2004, Renal insufficiency and mortality from acute coronary syndromes, Am Heart J, 147, 623, 10.1016/j.ahj.2003.12.010
Yan, 2006, Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes, Can J Cardiol, 22, 115, 10.1016/S0828-282X(06)70249-5
Wison, 2003, Renal function and risk stratification in acute coronary syndromes, Am J Cardiol, 91, 1051, 10.1016/S0002-9149(03)00147-4
Hamm, 1999, Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels: c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators, N Engl J Med, 340, 1623, 10.1056/NEJM199905273402103
Heeschen, 1999, Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban, Lancet, 354, 1757, 10.1016/S0140-6736(99)10285-X
Lindahl, 1997, Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection, J Am Coll Cardiol, 29, 43, 10.1016/S0735-1097(96)00447-0
Yusuf, 2001, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med, 345, 494, 10.1056/NEJMoa010746
Kastrati, 2006, Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial, JAMA, 295, 1531, 10.1001/jama.295.13.joc60034
1999, Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study, Lancet, 354, 708, 10.1016/S0140-6736(99)07349-3
Kleiman, 2002, Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes, J Am Coll Cardiol, 40, 1044, 10.1016/S0735-1097(02)02119-8
Marin, 1992, Use of rapid serial sampling of creatine kinase MB for very early detection of myocardial infarction in patients with acute chest pain, Am Heart J, 123, 354, 10.1016/0002-8703(92)90646-D
Young, 1997, Serial creatine kinase-MB results are a sensitive indicator of acute myocardial infarction in chest pain patients with nondiagnostic electrocardiograms: the second Emergency Medicine Cardiac Research Group Study, Acad Emerg Med, 4, 869, 10.1111/j.1553-2712.1997.tb03812.x
Apple, 1999, Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction, Clin Chem, 45, 199, 10.1093/clinchem/45.2.199
Fesmire, 1998, Serial creatinine kinase (CK) MB testing during the emergency department evaluation of chest pain: utility of a 2-hour deltaCK-MB of _1.6ng/ml, Am Heart J, 136, 237, 10.1053/hj.1998.v136.89571
Fesmire, 2003, Early use of glycoprotein IIb/IIIa inhibitors in the ED treatment of non-STsegment elevation acute coronary syndromes: a local quality improvement initiative, Am J Emerg Med, 21, 302, 10.1016/S0735-6757(03)00027-5
Lindahl, 1995, Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring, Coron Artery Dis, 6, 321, 10.1097/00019501-199504000-00009
Stork, 2000, Diagnostic and prognostic role of myoglobin in patients with suspected acute coronary syndrome, Am J Cardiol, 86, 1371, 10.1016/S0002-9149(00)01246-7
McCord, 2001, Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I, Circulation, 104, 1483, 10.1161/hc3801.096336
Ng, 2001, Ninety-minute accelerated critical pathway for chest pain evaluation, Am J Cardiol, 88, 611, 10.1016/S0002-9149(01)01801-X
Sallach, 2004, A change in serum myoglobin to detect acute myocardial infarction in patients with normal troponin I levels, Am J Cardiol, 94, 864, 10.1016/j.amjcard.2004.06.019
de Winter, 2000, Diagnostic accuracy of myoglobin concentration for the early diagnosis of acute myocardial infarction, Ann Emerg Med, 35, 113, 10.1016/S0196-0644(00)70129-6
Eggers, 2004, Diagnostic value of serial measurement of cardiac markers in patients with chest pain:limited value of adding myoglobin to troponin I for exclusion of myocardial infarction, Am Heart J, 148, 574, 10.1016/j.ahj.2004.04.030
Kontos, 1997, Use of the combination of myoglobin and CK-MB mass for the rapid diagnosis of acute myocardial infarction, Am J Emerg Med, 15, 14, 10.1016/S0735-6757(97)90040-1
Hamm, 2000, A classification of unstable angina revisited, Circulation, 102, 118, 10.1161/01.CIR.102.1.118
Rao, 2003, Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes, Am J Cardiol, 91, 936, 10.1016/S0002-9149(03)00107-3
Sabatine, 2002, Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide, Circulation, 105, 1760, 10.1161/01.CIR.0000015464.18023.0A
Morrow, 2003, Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-STelevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18, J Am Coll Cardiol, 41, 1264, 10.1016/S0735-1097(03)00168-2
Roy, 2004, Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T, Int J Cardiol, 97, 297, 10.1016/j.ijcard.2004.05.042
Peacock, 2006, Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department, Am Heart J, 152, 253, 10.1016/j.ahj.2005.12.024
Wollert, 2007, Prognostic value of growthdifferentiation factor-15 in patients with non–ST-elevation acute coronary syndrome, Circulation, 115, 962, 10.1161/CIRCULATIONAHA.106.650846
Kruskal, 1987, Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease, N Engl J Med, 317, 1361, 10.1056/NEJM198711263172201
Tataru, 1999, D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction, Eur Heart J, 20, 1493, 10.1053/euhj.1999.1519
Oldgren, 2001, Coagulation activity and clinical outcome in unstable coronary artery disease, Arterioscler Thromb Vasc Biol, 21, 1059, 10.1161/01.ATV.21.6.1059
Eikelboom, 2002, Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes, Eur Heart J, 23, 1771, 10.1053/euhj.2000.3234
Gum, 2001, Profile and prevalence of aspirin resistance in patients with cardiovascular disease, Am J Cardiol, 88, 230, 10.1016/S0002-9149(01)01631-9
Labarthe, 2005, Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug, J Am Coll Cardiol, 46, 638, 10.1016/j.jacc.2005.02.092
Lev, 2006, Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance, J Am Coll Cardiol, 47, 27, 10.1016/j.jacc.2005.08.058
Oltrona, 1997, C-reactive protein elevation and early outcome in patients with unstable angina pectoris, Am J Cardiol, 80, 1002, 10.1016/S0002-9149(97)00593-6
Morrow, 1998, C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy, J Am Coll Cardiol, 31, 1460, 10.1016/S0735-1097(98)00136-3
Ridker, 2005, C-reactive protein levels and outcomes after statin therapy, N Engl J Med, 352, 20, 10.1056/NEJMoa042378
Biasucci, 1996, Elevated levels of interleukin-6 in unstable angina, Circulation, 94, 874, 10.1161/01.CIR.94.5.874
Ghaisas, 1997, Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina, Am J Cardiol, 80, 617, 10.1016/S0002-9149(97)00432-3
Lund, 2003, Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation, Circulation, 108, 1924, 10.1161/01.CIR.0000096054.18485.07
Brennan, 2003, Prognostic value of myeloperoxidase in patients with chest pain, N Engl J Med, 349, 1595, 10.1056/NEJMoa035003
Galvani, 2004, N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes, Circulation, 110, 128, 10.1161/01.CIR.0000134480.06723.D8
de Lemos, 2002, Brain natriuretic peptide measurement in acute coronary syndromes: ready for clinical application?, Circulation, 106, 2868, 10.1161/01.CIR.0000042763.07757.C0
Omland, 2002, Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes, Am J Cardiol, 89, 463, 10.1016/S0002-9149(01)02271-8
Jernberg, 2002, N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation, J Am Coll Cardiol, 40, 437, 10.1016/S0735-1097(02)01986-1
Cannon, 1999, Critical pathways for acute coronary syndromes, 611
Gibler, 1995, A rapid diagnostic and treatment center for patients with chest pain in the emergency department, Ann Emerg Med, 25, 1, 10.1016/S0196-0644(95)70347-0
Graff, 1995, American College of Emergency Physicians information paper, Am J Cardiol, 76, 1036, 10.1016/S0002-9149(99)80291-4
Brillman, 1995, Management of observation units, Ann Emerg Med, 25, 823, 10.1016/S0196-0644(95)70215-6
Graff, 1997, Impact on the care of the emergency department chest pain patient from the chest pain evaluation registry (CHEPER) study, Am J Cardiol, 80, 563, 10.1016/S0002-9149(97)00422-0
Gomez, 1996, An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO), J Am Coll Cardiol, 28, 25, 10.1016/0735-1097(96)00093-9
Newby, 1998, The chest-pain unit—ready for prime time (editorial)?, N Engl J Med, 339, 1930, 10.1056/NEJM199812243392612
Kuntz, 1999, Costeffectiveness of diagnostic strategies for patients with chest pain, Ann Intern Med, 130, 709, 10.7326/0003-4819-130-9-199905040-00002
Garber, 1999, Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease, Ann Intern Med, 130, 719, 10.7326/0003-4819-130-9-199905040-00003
Fuster, 2005, Frontiers in cardiovascular magnetic resonance, Circulation, 112, 135, 10.1161/01.CIR.0000155618.37779.A0
Klem, 2006, Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging, J Am Coll Cardiol, 47, 1630, 10.1016/j.jacc.2005.10.074
Raff, 2005, Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography, J Am Coll Cardiol, 46, 552, 10.1016/j.jacc.2005.05.056
Mollet, 2005, High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography, Circulation, 112, 2318, 10.1161/CIRCULATIONAHA.105.533471
Fine, 2006, Comparison of accuracy of 64-slice cardiovascular computed tomography with coronary angiography in patients with suspected coronary artery disease, Am J Cardiol, 97, 173, 10.1016/j.amjcard.2005.08.021
Armstrong, 1998, Stable ischemic syndromes, 349
Cheitlin, 1999, ACC/AHA expert consensus document: use of sildenafil (Viagra) in patients with cardiovascular disease, J Am Coll Cardiol, 33, 273, 10.1016/S0735-1097(98)00656-1
Deleted in proof.
1999, 1331
Esposito, 1998, Converting i.v. nitroglycerin therapy to nitroglycerin ointment therapy:a comparison of two methods, Am J Crit Care, 7, 123, 10.4037/ajcc1998.7.2.123
Dellborg, 1991, Buccal versus intravenous nitroglycerin in unstable angina pectoris, Eur J Clin Pharmacol, 41, 5, 10.1007/BF00280098
Yusuf, 1988, Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials, Lancet, 1, 1088, 10.1016/S0140-6736(88)91906-X
1995, ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction, Lancet, 345, 669, 10.1016/S0140-6736(95)90865-X
1994, GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction, Lancet, 343, 1115
Figueras, 1991, Rebound myocardial ischaemia following abrupt interruption of intravenous nitroglycerin infusion in patients with unstable angina at rest, Eur Heart J, 12, 405, 10.1093/oxfordjournals.eurheartj.a059909
Meine, 2005, Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative, Am Heart J, 149, 1043, 10.1016/j.ahj.2005.02.010
Roberts, 1991, Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction, Circulation, 83, 422, 10.1161/01.CIR.83.2.422
Van de Werf, 1993, Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy, J Am Coll Cardiol, 22, 407, 10.1016/0735-1097(93)90044-2
Pfisterer, 1998, Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience, J Am Coll Cardiol, 32, 634, 10.1016/S0735-1097(98)00279-4
Chen, 2005, Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial, Lancet, 366, 1622, 10.1016/S0140-6736(05)67661-1
Poole-Wilson, 2003, Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial, Lancet, 362, 7, 10.1016/S0140-6736(03)13800-7
Carlberg, 2004, Atenolol in hypertension:is it a wise choice?, Lancet, 364, 1684, 10.1016/S0140-6736(04)17355-8
Dargie, 2001, Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial, Lancet, 537, 1385
Yusuf, 1988, Overview of results of randomized clinical trials in heart disease, JAMA, 260, 2259, 10.1001/jama.1988.03410150107041
Ellis, 2003, Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport trials, J Interv Cardiol, 16, 299, 10.1034/j.1600-6143.2003.08062.x
White, 1998, Unstable angina, 379
Furberg, 1995, Nifedipine: dose-related increase in mortality in patients with coronary heart disease, Circulation, 92, 1326, 10.1161/01.CIR.92.5.1326
Lubsen, 1987, Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT), Am J Cardiol, 60, 18A, 10.1016/0002-9149(87)90494-2
Beevers, 1996, Short acting dihydropyridine (vasodilating) calcium channel blockers for hypertension: is there a risk?, BMJ, 312, 1143, 10.1136/bmj.312.7039.1143
Gibson, 1986, Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction, N Engl J Med, 315, 423, 10.1056/NEJM198608143150704
Hansen, 1997, Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone, Am J Cardiol, 79, 738, 10.1016/S0002-9149(96)00860-0
Opie, 1996, Pharmacologic options for treatment of ischemic heart disease, 22
Pepine, 1998, Verapamil use in patients with cardiovascular disease: an overview of randomized trials, Clin Cardiol, 21, 633, 10.1002/clc.4960210906
1984, Verapamil in acute myocardial infarction, Eur Heart J, 5, 516, 10.1093/oxfordjournals.eurheartj.a061701
Boden, 1991, Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction, Am J Cardiol, 67, 335, 10.1016/0002-9149(91)90038-M
Tijssen, 1987, Nifedipine and metoprolol in unstable angina:findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT), J Cardiovasc Pharmacol, 10, S15
Held, 1989, Calcium channel blockers in acute myocardial infarction and unstable angina: an overview, BMJ, 299, 1187, 10.1136/bmj.299.6709.1187
Hansen, 1996, Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction, Am J Cardiol, 77, 16D, 10.1016/S0002-9149(96)00303-7
Theroux, 1998, Intravenous diltiazem in acute myocardial infarction: diltiazem as adjunctive therapy to activase (DATA) trial, J Am Coll Cardiol, 32, 620, 10.1016/S0735-1097(98)00281-2
Yusuf, 1992, Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions, Lancet, 340, 1173, 10.1016/0140-6736(92)92889-N
Rutherford, 1994, Effects of captopril on ischemic events after myocardial infarction: results of the Survival and Ventricular Enlargement trial, Circulation, 90, 1731, 10.1161/01.CIR.90.4.1731
1998, Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials, Circulation, 97, 2202, 10.1161/01.CIR.97.22.2202
Gustafsson, 1999, Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction, J Am Coll Cardiol, 34, 83, 10.1016/S0735-1097(99)00146-1
Yusuf, 2000, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients, N Engl J Med, 342, 145, 10.1056/NEJM200001203420301
Buch, 2005, The long-term impact of the angiotensin-converting enzyme inhibitor trandolapril on mortality and hospital admissions in patients with left ventricular dysfunction after a myocardial infarction:follow-up to 12 years, Eur Heart J, 26, 145, 10.1093/eurheartj/ehi021
Teo, 2002, Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review, Lancet, 360, 1037, 10.1016/S0140-6736(02)11138-X
Pfeffer, 2003, Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both, N Engl J Med, 349, 1893, 10.1056/NEJMoa032292
Pfeffer, 2003, Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme, Lancet, 362, 759, 10.1016/S0140-6736(03)14282-1
Pitt, 2003, Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 348, 1309, 10.1056/NEJMoa030207
Pitt, 1999, The effect of spironolactone on morbidity and mortality in patients with severe heart failure, N Engl J Med, 341, 709, 10.1056/NEJM199909023411001
TenVaarwerk, 1999, Clinical outcome of patients treated with spinal cord stimulation for therapeutically refractory angina pectoris, Heart, 82, 82, 10.1136/hrt.82.1.82
Arora, 1999, The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes, J Am Coll Cardiol, 33, 1833, 10.1016/S0735-1097(99)00140-0
Conti, 1999, EECP-enhanced external counterpulsation, J Am Coll Cardiol, 33, 1841
Hautvast, 1998, Spinal cord stimulation in chronic intractable angina pectoris: a randomized, controlled efficacy study, Am Heart J, 136, 1114, 10.1016/S0002-8703(98)70171-1
Patel, 1999, Cardioprotection by opening of the K(ATP) channel in unstable angina, Eur Heart J, 20, 51, 10.1053/euhj.1998.1354
Chaitman, 2004, Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina, J Am Coll Cardiol, 43, 1375, 10.1016/j.jacc.2003.11.045
Antzelevitch, 2004, Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties, Circulation, 110, 904, 10.1161/01.CIR.0000139333.83620.5D
Morrow, 2006, Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-STelevation acute coronary syndromes (MERLIN)-TIMI 36 trial, Am Heart J, 151, 1186, 10.1016/j.ahj.2006.01.004
Morrow, 2007, Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLINTIMI 36 randomized trial, JAMA, 297, 1775, 10.1001/jama.297.16.1775
Stone, 2003, Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry, J Am Coll Cardiol, 41, 1940, 10.1016/S0735-1097(03)00400-5
Kearney, 2006, Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis?, BMJ, 332, 1302, 10.1136/bmj.332.7553.1302
McGettigan, 2006, Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2, JAMA, 296, 1633, 10.1001/jama.296.13.jrv60011
Gislason, 2006, Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction, Circulation, 113, 2906, 10.1161/CIRCULATIONAHA.106.616219
Gibson, 2006, Association of treatment with nonsteroidal anti-inflammatory agents (NSAIDS) on study entry with 30 day adverse outcomes among ST elevation MI (STEMI) patients treated with fibrinolytic agent, Circulation, 114, 697
1994, Collaborative overview of randomised trials of antiplatelet therapy—I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, BMJ, 308, 81, 10.1136/bmj.308.6921.81
Ridker, 1997, Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men, N Engl J Med, 336, 973, 10.1056/NEJM199704033361401
Lewis, 1983, Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study, N Engl J Med, 309, 396, 10.1056/NEJM198308183090703
Cairns, 1985, Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian multicenter trial, N Engl J Med, 313, 1369, 10.1056/NEJM198511283132201
Théroux, 1988, Aspirin, heparin, or both to treat acute unstable angina, N Engl J Med, 319, 1105, 10.1056/NEJM198810273191701
1990, Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease, Lancet, 336, 827, 10.1016/0140-6736(90)92336-G
Cohen, 1994, Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users: primary end points analysis from the ATACS trial, Circulation, 89, 81, 10.1161/01.CIR.89.1.81
Gurfinkel, 1995, Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia, J Am Coll Cardiol, 26, 313, 10.1016/0735-1097(95)80001-W
1996, Low-molecular-weight heparin during instability in coronary artery disease, Lancet, 347, 561, 10.1016/S0140-6736(96)91270-2
1997, Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study, Lancet, 349, 1429, 10.1016/S0140-6736(96)10452-9
1998, International, randomized, controlled trial of lamifiban (a plateletglycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina, Circulation, 97, 2386, 10.1161/01.CIR.97.24.2386
1998, A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina, N Engl J Med, 338, 1498, 10.1056/NEJM199805213382103
2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71
2002
Sagar, 1999, A comparative bioavailability study of different aspirin formulations using on-line multidimensional chromatography, J Pharm Biomed Anal, 21, 383, 10.1016/S0731-7085(99)00177-6
Ferrari, 2005, Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis, J Am Coll Cardiol, 45, 456, 10.1016/j.jacc.2004.11.041
McFadden, 2004, Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy, Lancet, 364, 1519, 10.1016/S0140-6736(04)17275-9
Spertus, 2006, Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry, Circulation, 113, 2803, 10.1161/CIRCULATIONAHA.106.618066
Song, 1999, Interaction of ACE inhibitors and aspirin in patients with congestive heart failure, Ann Pharmacother, 33, 375, 10.1345/aph.18129
Schror, 1993, The basic pharmacology of ticlopidine and clopidogrel, Platelets, 4, 252, 10.3109/09537109309013225
Lai, 2002, Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use, N Engl J Med, 346, 2033, 10.1056/NEJMoa012877
Chan, 2005, Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding, N Engl J Med, 532, 238, 10.1056/NEJMoa042087
Leontiadis, 2005, Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding, BMJ, 330, 568, 10.1136/bmj.38356.641134.8F
Balsano, 1990, Antiplatelet treatment with ticlopidine in unstable angina: a controlled multicenter clinical trial, Circulation, 82, 17, 10.1161/01.CIR.82.1.17
Love, 1998, Adverse haematological effects of ticlopidine, Drug Saf, 19, 89, 10.2165/00002018-199819020-00002
1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3
Bennett, 2000, Thrombotic thrombocytopenic purpura associated with clopidogrel, N Engl J Med, 342, 1773, 10.1056/NEJM200006153422402
Mehta, 2006, Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery, J Am Coll Cardiol, 48, 281, 10.1016/j.jacc.2006.04.029
Muller, 2000, A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents, Circulation, 101, 590, 10.1161/01.CIR.101.6.590
Mehta, 2001, Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study, Lancet, 358, 527, 10.1016/S0140-6736(01)05701-4
Schleinitz, 2005, A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes:clopidogrel plus aspirin versus aspirin alone, Ann Intern Med, 142, 251, 10.7326/0003-4819-142-4-200502150-00007
Kotani, 2006, Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings, J Am Coll Cardiol, 47, 2108, 10.1016/j.jacc.2005.11.092
Lu scher, 2007, Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications, Circulation, 115, 1051, 10.1161/CIRCULATIONAHA.106.675934
Pfisterer, 2006, Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents, J Am Coll Cardiol, 48, 2584, 10.1016/j.jacc.2006.10.026
Park, 2006, Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during longterm follow-up, Am J Cardiol, 98, 352, 10.1016/j.amjcard.2006.02.039
Bavry, 2006, Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials, Am J Med, 119, 1056, 10.1016/j.amjmed.2006.01.023
Spaulding, 2007, A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents, N Engl J Med, 356, 989, 10.1056/NEJMoa066633
Stone, 2007, Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents, N Engl J Med, 356, 998, 10.1056/NEJMoa067193
Mauri, 2007, Stent thrombosis in randomized clinical trials of drug-eluting stents, N Engl J Med, 356, 1020, 10.1056/NEJMoa067731
Kastrati, 2007, Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents, N Engl J Med, 356, 1030, 10.1056/NEJMoa067484
Maisel, 2007, Unanswered questions—drug-eluting stents and the risk of late thrombosis, N Engl J Med, 356, 981, 10.1056/NEJMp068305
Ellis, 2007, Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drugeluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years, J Am Coll Cardiol, 49, 1043, 10.1016/j.jacc.2007.01.015
Steinhubl, 2002, Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention:a randomized controlled trial, JAMA, 288, 2411, 10.1001/jama.288.19.2411
Steinhubl, 2006, Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention, J Am Coll Cardiol, 47, 939, 10.1016/j.jacc.2005.10.047
van der Heijden, 2004, Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation, J Am Coll Cardiol, 44, 20, 10.1016/j.jacc.2004.02.056
Fox, 2004, Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome:the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial, Circulation, 110, 1202, 10.1161/01.CIR.0000140675.85342.1B
Gaspoz, 2002, Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease, N Engl J Med, 346, 1800, 10.1056/NEJM200206063462309
Bertrand, 2002, Management of acute coronary syndromes in patients presenting without persistent STsegment elevation, Eur Heart J, 23, 1809, 10.1053/euhj.2002.3385
Grines, 2007, Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents, Circulation, 115, 813, 10.1161/CIRCULATIONAHA.106.180944
Nordmann, 2006, Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis, Eur Heart J, 27, 2784, 10.1093/eurheartj/ehl282
Yusuf, 2003, Early and late effects of clopidogrel in patients with acute coronary syndromes, Circulation, 107, 966, 10.1161/01.CIR.0000051362.96946.15
Bhatt, 2006, Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events, N Engl J Med, 354, 1706, 10.1056/NEJMoa060989
Chu, 2004, Does clopidogrel increase blood loss following coronary artery bypass surgery?, Ann Thorac Surg, 78, 1536, 10.1016/j.athoracsur.2004.03.028
Deleted in proof.
Cadroy, 2000, Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans, Circulation, 101, 2823, 10.1161/01.CIR.101.24.2823
Helft, 2000, Acute antithrombotic effect of a front-loaded regimen of clopidogrel in patients with atherosclerosis on aspirin, Arterioscler Thromb Vasc Biol, 20, 2316, 10.1161/01.ATV.20.10.2316
Serebruany, 2005, Variability in platelet responsiveness to clopidogrel among 544 individuals, J Am Coll Cardiol, 45, 246, 10.1016/j.jacc.2004.09.067
Matetzky, 2004, Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction, Circulation, 109, 3171, 10.1161/01.CIR.0000130846.46168.03
Wiviott, 2004, Clopidogrel resistance: a new chapter in a fast-moving story, Circulation, 109, 3064, 10.1161/01.CIR.0000134701.40946.30
Gurbel, 2005, The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting, J Am Coll Cardiol, 45, 1392, 10.1016/j.jacc.2005.01.030
Ferguson, 2004, Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial, JAMA, 292, 45
Yusuf, 2006, Comparison of fondaparinux and enoxaparin in acute coronary syndromes, N Engl J Med, 354, 1464, 10.1056/NEJMoa055443
Stone, 2006, Bivalirudin for patients with acute coronary syndromes, N Engl J Med, 355, 2203, 10.1056/NEJMoa062437
Lincoff, 2003, Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial, JAMA, 289, 853, 10.1001/jama.289.7.853
Kaul, 2005, Trials and tribulations of non-inferiority: the ximelagatran experience, J Am Coll Cardiol, 46, 1986, 10.1016/j.jacc.2005.07.062
Kaul, 2006, Good enough: a primer on the analysis and interpretation of noninferiority trials, Ann Intern Med, 145, 62, 10.7326/0003-4819-145-1-200607040-00011
D'Agostino, 2003, Non-inferiority trials: design concepts and issues—the encounters of academic consultants in statistics, Stat Med, 22, 169, 10.1002/sim.1425
Stone, 1986, Kinetics of the inhibition of thrombin by hirudin, Biochemistry, 25, 4622, 10.1021/bi00364a025
Yusuf, 2006, Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial, JAMA, 295, 1519, 10.1001/jama.295.13.joc60038
Antman, 2006, Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction, N Engl J Med, 354, 1477, 10.1056/NEJMoa060898
Telford, 1981, Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome, Lancet, 1, 1225, 10.1016/S0140-6736(81)92399-0
Williams, 1986, Anticoagulant treatment of unstable angina, Br J Clin Pract, 40, 114, 10.1111/j.1742-1241.1986.tb07927.x
Theroux, 1993, Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina, Circulation, 88, 2045, 10.1161/01.CIR.88.5.2045
Neri, 1990, Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina, Lancet, 335, 615, 10.1016/0140-6736(90)90407-V
Holdright, 1994, Comparison of the effect of heparin and aspirin versus aspirin alone on transient myocardial ischemia and in-hospital prognosis in patients with unstable angina, J Am Coll Cardiol, 24, 39, 10.1016/0735-1097(94)90539-8
Cohen, 1990, Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group), Am J Cardiol, 66, 1287, 10.1016/0002-9149(90)91155-Y
Oler, 1996, Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina, JAMA, 276, 811, 10.1001/jama.1996.03540100055028
Theroux, 1992, Reactivation of unstable angina after the discontinuation of heparin, N Engl J Med, 327, 141, 10.1056/NEJM199207163270301
Serruys, 1995, A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty, N Engl J Med, 333, 757, 10.1056/NEJM199509213331203
1996, A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes, N Engl J Med, 335, 775, 10.1056/NEJM199609123351103
Granger, 1996, Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial, Circulation, 93, 870, 10.1161/01.CIR.93.5.870
Granger, 1995, Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes, Circulation, 91, 1929, 10.1161/01.CIR.91.7.1929
Hirsh, 1998, Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety, Chest, 114, 489S, 10.1378/chest.114.5_Supplement.489S
Hassan, 1995, Improved anticoagulation with a weight-adjusted heparin nomogram in patients with acute coronary syndromes: a randomized trial, J Thromb Thrombolysis, 2, 245, 10.1007/BF01062717
Becker, 1999, A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and pointof-care coagulation monitoring in hospitalized patients with active thromboembolic disease: Antithrombotic Therapy Consortium Investigators, Am Heart J, 137, 59, 10.1016/S0002-8703(99)70460-6
Hochman, 1999, A new regimen for heparin use in acute coronary syndromes, Am Heart J, 138, 313, 10.1016/S0002-8703(99)70118-3
Hirsh, 2004, Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 188S, 10.1378/chest.126.3_suppl.188S
Hochman, 1999, A new regimen for heparin use in acute coronary syndromes, Am Heart J, 138, 313, 10.1016/S0002-8703(99)70118-3
Oliveira, 2005, Intravenous unfractionated heparin, patient profile, and the magnitude of thrombocytopenia are associated with heparin-induced thrombocytopenia (HIT) antibodies: insights from the CATCH Registry (abstr), Eur Heart J, 725
Oliveira, 2006, J Am Coll Cardiol, 251A
Ohman, 2005, Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease, J Thromb Thrombolysis, 19, 11, 10.1007/s11239-005-0850-7
Warkentin, 1995, Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin, N Engl J Med, 332, 1330, 10.1056/NEJM199505183322003
Warkentin, 2004, Clinical picture of heparin-induced thrombocytopenia, 53
Smythe, 2005, Delayed-onset heparininduced thrombocytopenia, Ann Emerg Med, 45, 417, 10.1016/j.annemergmed.2004.08.005
Warkentin, 2001, Delayed-onset heparin-induced thrombocytopenia and thrombosis, Ann Intern Med, 135, 502, 10.7326/0003-4819-135-7-200110020-00009
Collet, 2001, Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris, Circulation, 103, 658, 10.1161/01.CIR.103.5.658
Klein, 1997, Comparison of lowmolecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease, Circulation, 96, 61, 10.1161/01.CIR.96.1.61
Cohen, 2002, Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study, Am Heart J, 144, 470, 10.1067/mhj.2002.126115
Goodman, 2003, Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide, Circulation, 107, 238, 10.1161/01.CIR.0000050144.67910.13
Blazing, 2004, Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-STsegment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial, JAMA, 292, 55, 10.1001/jama.292.1.55
Michalis, 2003, Enoxaparin versus tinzaparin in non-ST-segment elevation acute coronary syndromes:the EVET trial, Am Heart J, 146, 304, 10.1016/S0002-8703(03)00179-0
Antman, 2003, Low molecular weight heparins for acute coronary syndrome: tackling the issues head-on, Am Heart J, 146, 191, 10.1016/S0002-8703(03)00180-7
Xiao, 1998, Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecularweight heparin and with a direct thrombin inhibitor, Circulation, 97, 251, 10.1161/01.CIR.97.3.251
Mahaffey, 2005, Exploring the role of enoxaparin in the management of high-risk patients with non-ST-elevation acute coronary syndromes: the SYNERGY trial, Am Heart J, 149, S81, 10.1016/j.ahj.2005.02.023
Mark, 1998, Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial, Circulation, 97, 1702, 10.1161/01.CIR.97.17.1702
1999, Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study, Lancet, 354, 701, 10.1016/S0140-6736(99)07350-X
1994, Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes, Circulation, 90, 1631, 10.1161/01.CIR.90.4.1631
Antman, 1996, Hirudin in acute myocardial infarction: Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial, Circulation, 94, 911, 10.1161/01.CIR.94.5.911
Antman, 1994, Hirudin in acute myocardial infarction: safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A trial, Circulation, 90, 1624, 10.1161/01.CIR.90.4.1624
1997, Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: a pilot study, Circulation, 96, 769, 10.1161/01.CIR.96.3.769
1999, Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial, Lancet, 353, 429, 10.1016/S0140-6736(98)07332-2
Roe, 2001, Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention, Am J Cardiol, 88, 1403, 10.1016/S0002-9149(01)02119-1
2002, Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data, Lancet, 359, 294, 10.1016/S0140-6736(02)07495-0
Antman, 2003, Should bivalirudin replace heparin during percutaneous coronary interventions?, JAMA, 289, 903, 10.1001/jama.289.7.903
Lincoff, 2004, Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial, JAMA, 292, 696, 10.1001/jama.292.6.696
Stone, 2007, Routine upstream initiation vs. deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes, JAMA, 297, 591, 10.1001/jama.297.6.591
Mahaffey, 2007, Optimal timing for use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes, JAMA, 297, 636, 10.1001/jama.297.6.636
Stone, 2007, Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial, Lancet, 369, 907, 10.1016/S0140-6736(07)60450-4
Waksman, 2007, ACUITY-PCI: one drug does not fit all, Lancet, 369, 881, 10.1016/S0140-6736(07)60421-8
White, 2001, Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial, Lancet, 358, 1855, 10.1016/S0140-6736(01)06887-8
Petersen, 2004, Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview, JAMA, 292, 89, 10.1001/jama.292.1.89
Deleted in proof.
Eikelboom, 2006, Adverse impact of bleeding on prognosis in patients with acute coronary syndromes, Circulation, 114, 774, 10.1161/CIRCULATIONAHA.106.612812
Williams, 1997, Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary study, J Am Coll Cardiol, 30, 364, 10.1016/S0735-1097(97)00153-8
Anand, 1998, Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results, Circulation, 98, 1064, 10.1161/01.CIR.98.11.1064
Anand, 1999, Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis, JAMA, 282, 2058, 10.1001/jama.282.21.2058
1997, Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction, Lancet, 350, 389, 10.1016/S0140-6736(97)01180-X
Fiore, 2002, Department of Veterans Affairs Cooperative Studies Program clinical trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study, Circulation, 105, 557, 10.1161/hc0502.103329
van Es, 2002, Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial, Lancet, 360, 109, 10.1016/S0140-6736(02)09409-6
Hurlen, 2002, Warfarin, aspirin, or both after myocardial infarction, N Engl J Med, 347, 969, 10.1056/NEJMoa020496
Kushner, 2005, Oral anticoagulation for atrial fibrillation after ST-elevation myocardial infarction: new evidence to guide clinical practice, Circulation, 112, 3212, 10.1161/CIRCULATIONAHA.105.579862
Stenestrand, 2005, Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA), Circulation, 112, 3225, 10.1161/CIRCULATIONAHA.105.552984
Lefkovits, 1995, Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine, N Engl J Med, 332, 1553, 10.1056/NEJM199506083322306
Coller, 1997, Monitoring platelet GP IIb/IIIa [corrected] antagonist therapy [editorial] (corrected and republished in Circulation 1998;97:5–9), Circulation, 96, 3828
Coller, 1999, Potential non-glycoprotein IIb/IIIa effects of abciximab, Am Heart J, 138, S1, 10.1053/hj.1999.v138.99078
Tam, 1998, Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrins, Circulation, 98, 1085, 10.1161/01.CIR.98.11.1085
Phillips, 1997, Clinical pharmacology of eptifibatide, Am J Cardiol, 80, 11B, 10.1016/S0002-9149(97)00572-9
Kleiman, 1998, Pharmacology of the intravenous platelet receptor glycoprotein IIb-IIIa antagonists, Coron Artery Dis, 9, 603, 10.1097/00019501-199809090-00008
Lynch, 1995, Nonpeptide glycoprotein IIb/IIIa inhibitors, J Pharmacol Exp Ther, 272, 20
Peter, 1998, Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors, Blood, 92, 3240, 10.1182/blood.V92.9.3240
2000, Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial, Lancet, 355, 337, 10.1016/S0140-6736(99)11179-6
Cannon, 2000, Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial, Circulation, 102, 149, 10.1161/01.CIR.102.2.149
O'Neill, 2000, Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization, N Engl J Med, 342, 1316, 10.1056/NEJM200005043421803
Topol, 2003, Randomized, doubleblind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease, Circulation, 108, 399, 10.1161/01.CIR.0000084501.48570.F6
1994, Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty, N Engl J Med, 330, 956, 10.1056/NEJM199404073301402
1997, Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization, N Engl J Med, 336, 1689, 10.1056/NEJM199706123362401
1998, Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade, Lancet, 352, 87, 10.1016/S0140-6736(98)06113-3
2002, Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes, Circulation, 105, 316, 10.1161/hc0302.102573
Simoons, 2001, Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial, Lancet, 357, 1915, 10.1016/S0140-6736(00)05060-1
Topol, 2001, Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization, N Engl J Med, 344, 1888, 10.1056/NEJM200106213442502
Kabbani, 2002, Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions, Am J Cardiol, 89, 647, 10.1016/S0002-9149(01)02319-0
1997, Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II, Lancet, 349, 1422, 10.1016/S0140-6736(96)10172-0
1997, Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty, Circulation, 96, 1445, 10.1161/01.CIR.96.5.1445
2000, Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial, Lancet, 356, 2037, 10.1016/S0140-6736(00)03400-0
Gratsianskii, 2004, [Do low risk patients undergoing percutaneous coronary intervention after pretreatment with clopidogrel need abciximab infusion? Results of ISAR-REACT study], Kardiologiia, 44, 80
Mukherjee, 2002, Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B), Am Heart J, 144, 995, 10.1067/mhj.2002.126118
Spacek, 2002, Value of first day angiography/angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicenter randomized trial, Eur Heart J, 23, 230, 10.1053/euhj.2001.2735
Boersma, 1999, Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention, Circulation, 100, 2045, 10.1161/01.CIR.100.20.2045
Deleted in proof.
Morrow, 2004, Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS), Am J Cardiol, 94, 774, 10.1016/j.amjcard.2004.05.065
Boersma, 2002, Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a metaanalysis of all major randomised clinical trials, Lancet, 359, 189, 10.1016/S0140-6736(02)07442-1
Berkowitz, 1998, Occurrence and clinical significance of thrombocytopenia in a population undergoing highrisk percutaneous coronary revascularization, J Am Coll Cardiol, 32, 311, 10.1016/S0735-1097(98)00252-6
McClure, 1999, Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome, Circulation, 99, 2892, 10.1161/01.CIR.99.22.2892
Cohen, 2002, Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-S.T-segment elevation acute coronary syndromes treated with tirofiban and aspirin:the A.C.U.T.E.I.I.study, Am Heart J, 144, 470, 10.1067/mhj.2002.126115
Baigent, 1998, ISIS-2:10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither, BMJ, 316, 1337, 10.1136/bmj.316.7141.1337
Franzosi, 1998, Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study, Circulation, 98, 2659, 10.1161/01.CIR.98.24.2659
1994, Indications for fibrinolytic therapy in suspended acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients, Lancet, 343, 311, 10.1016/S0140-6736(94)91161-4
de Winter, 2005, Early invasive versus selectively invasive management for acute coronary syndromes, N Engl J Med, 353, 1095, 10.1056/NEJMoa044259
McCullough, 1998, A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy, J Am Coll Cardiol, 32, 596, 10.1016/S0735-1097(98)00284-8
Boden, 1998, Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy, N Engl J Med, 338, 1785, 10.1056/NEJM199806183382501
1997, Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial, Lancet, 350, 461, 10.1016/S0140-6736(97)07298-X
Peterson, 1997, Risk stratification after myocardial infarction, Ann Intern Med, 126, 561, 10.7326/0003-4819-126-7-199704010-00012
Luchi, 1987, Comparison of medical and surgical treatment for unstable angina pectoris: results of a Veterans Administration Cooperative Study, N Engl J Med, 316, 977, 10.1056/NEJM198704163161603
Takaro, 1976, The VA cooperative randomized study of surgery for coronary arterial occlusive disease: II, Circulation, 54, 107
Antman, 1999, Assessment of the treatment effect of enoxparin for unstable angina/non-Q-wave myocardial infarction: TIMI11B-ESSENCE meta-analysis, Circulation, 100, 1602, 10.1161/01.CIR.100.15.1602
Neumann, 2003, Evaluation of prolonged antithrombotic pretreatment (“cooling-off” strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial, JAMA, 290, 1593, 10.1001/jama.290.12.1593
Smith, 2001, ACC/AHA guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Percutaneous Transluminal Coronary Angioplasty), Circulation, 103, 3019, 10.1161/01.CIR.103.24.3019
Bavry, 2004, Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-STsegment elevation acute coronary syndromes: a meta-analysis and review of the literature, Am J Cardiol, 93, 830, 10.1016/j.amjcard.2003.12.019
Mehta, 2005, Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials, JAMA, 293, 2908, 10.1001/jama.293.23.2908
Biondi-Zoccai, 2005, Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregression, Am Heart J, 149, 504, 10.1016/j.ahj.2004.10.026
Hirsch, 2007, Longterm outcome after an early invasive versus selective invasive treatment strategy in patients with non–ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study, Lancet, 369, 827, 10.1016/S0140-6736(07)60410-3
2007, Non–ST-elevation acute coronary syndromes (comment), Lancet, 369, 801, 10.1016/S0140-6736(07)60382-1
Fox, 2005, 5–year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome:the British Heart Foundation RITA 3 randomised trial, Lancet, 366, 914, 10.1016/S0140-6736(05)67222-4
Boden, 2007, Optimal medical therapy with or without PCI for stable coronary disease, N Engl J Med, 356, 1503, 10.1056/NEJMoa070829
Bavry, 2006, Benefit of early invasive therapy in acute coronary syndromes a meta-analysis of contemporary randomized clinical trials, J Am Coll Cardiol, 48, 1319, 10.1016/j.jacc.2006.06.050
Hoenig, 2006, Early invasive versus conservative strategies for unstable angina and non-ST-elevation myocardial infarction in the stent era, Cochrane Database Syst Rev, 3, 10.1002/14651858.CD004815.pub2
Wallentin, 2000, Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease, Lancet, 356, 9, 10.1016/S0140-6736(00)02427-2
Lagerqvist, 2006, 5–year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study, Lancet, 368, 998, 10.1016/S0140-6736(06)69416-6
Greenbaum, 2001, Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes, J Am Coll Cardiol, 37, 492, 10.1016/S0735-1097(00)01143-8
Lagerqvist, 2001, Is early invasive treatment of unstable coronary artery disease equally effective for both women and men?, J Am Coll Cardiol, 38, 41, 10.1016/S0735-1097(01)01308-0
Mueller, 2002, Women do have an improved long-term outcome after non-ST-elevation acute coronary syndromes treated very early and predominantly with percutaneous coronary intervention: a prospective study in 1,450 consecutive patients, J Am Coll Cardiol, 40, 245, 10.1016/S0735-1097(02)01949-6
Clayton, 2004, Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction?, Eur Heart J, 25, 1641, 10.1016/j.ehj.2004.07.032
Eagle, 2004, Circulation, 110, e340
Madsen, 1997, Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI), Circulation, 96, 748, 10.1161/01.CIR.96.3.748
Pepine, 1994, The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial, J Am Coll Cardiol, 24, 1, 10.1016/0735-1097(94)90534-7
Knatterud, 1994, Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12–week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study, J Am Coll Cardiol, 24, 11, 10.1016/0735-1097(94)90535-5
Erne, 2007, Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial, JAMA, 297, 1985, 10.1001/jama.297.18.1985
Yusuf, 1998, Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation, Lancet, 352, 507, 10.1016/S0140-6736(97)11162-X
Deleted in proof.
Stone, 1999, Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction: a TIMI IIIB database study, Eur Heart J, 20, 1084, 10.1053/euhj.1998.1480
Deleted in proof.
Bugiardini, 1991, Angiographic morphology in unstable angina and its relation to transient myocardial ischemia and hospital outcome, Am J Cardiol, 67, 460, 10.1016/0002-9149(91)90004-5
Diver, 1994, Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial), Am J Cardiol, 74, 531, 10.1016/0002-9149(94)90739-0
Glaser, 2002, Benefit of an early invasive management strategy in women with acute coronary syndromes, JAMA, 288, 3124, 10.1001/jama.288.24.3124
Albertsson, 1997, Morbidity and use of medical resources in patients with chest pain and normal or near-normal coronary arteries, Am J Cardiol, 79, 299, 10.1016/S0002-9149(96)00751-5
Potts, 1993, Psychosocial outcome and use of medical resources in patients with chest pain and normal or near-normal coronary arteries: a long-term follow-up study, Q J Med, 86, 583
Cantor, 2006, Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal, Catheter Cardiovasc Interv, 69, 73, 10.1002/ccd.20897
Miltenburg-van Zijl, 1995, Incidence and follow-up of Braunwald subgroups in unstable angina pectoris, J Am Coll Cardiol, 25, 1286, 10.1016/0735-1097(95)00009-S
Nyman, 1993, Very early risk stratification by electrocardiogram at rest in men with suspected unstable coronary heart disease, J Intern Med, 134, 293, 10.1111/j.1365-2796.1993.tb00746.x
Gibbons, 2002, ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines), Circulation, 106, 1883, 10.1161/01.CIR.0000034670.06526.15
Kligfield, 2006, Exercise electrocardiogram testing: beyond the ST segment, Circulation, 114, 2070, 10.1161/CIRCULATIONAHA.105.561944
Mark, 1991, Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease, N Engl J Med, 325, 849, 10.1056/NEJM199109193251204
O'Rourke, 1986, Guidelines for clinical use of cardiac radionuclide imaging, December 1986, J Am Coll Cardiol, 8, 1471, 10.1016/S0735-1097(86)80326-6
Cheitlin, 1997, ACC/AHA guidelines for the clinical application of chocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography), Circulation, 95, 1686, 10.1161/01.CIR.95.6.1686
Manning
Nyman, 1992, The predictive value of silent ischemia at an exercise test before discharge after an episode of unstable coronary artery disease, Am Heart J, 123, 324, 10.1016/0002-8703(92)90642-9
Starling, 1981, Treadmill exercise tests predischarge and six weeks post-myocardial infarction to detect abnormalities of known prognostic value, Ann Intern Med, 94, 721, 10.7326/0003-4819-94-6-721
Marwick, 1995, Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women, J Am Coll Cardiol, 26, 335, 10.1016/0735-1097(95)80004-Z
Larsson, 1991, Should the exercise test (ET) be performed at discharge or one month later after an episode of unstable angina or non-Q-wave myocardial infarction?, Int J Card Imaging, 7, 7, 10.1007/BF01797676
Goyal, 2002, Stress test criteria used in the conservative arm of the FRISC-II trial underdetects surgical coronary artery disease when applied to patients in the VANQWISH trial, J Am Coll Cardiol, 39, 1601, 10.1016/S0735-1097(02)01841-7
Jones, 1996, Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease, J Thorac Cardiovasc Surg, 111, 1013, 10.1016/S0022-5223(96)70378-1
Hannan, 1999, A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty, J Am Coll Cardiol, 33, 63, 10.1016/S0735-1097(98)00540-3
Rahimtoola, 1983, Ten-year survival after coronary bypass surgery for unstable angina, N Engl J Med, 308, 676, 10.1056/NEJM198303243081202
Levin, 1998, Acute and late clinical outcome after rotational atherectomy for complex coronary disease, Cathet Cardiovasc Diagn, 45, 122, 10.1002/(SICI)1097-0304(199810)45:2<122::AID-CCD5>3.0.CO;2-E
Rosenblum, 1991, The transluminal extraction catheter device: atherectomy and removal of an intracoronary thrombus, J Inv Cardiol, 310
Williams, 1996, Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction:observations from the TIMI IIIB Trial, Circulation, 94, 2749, 10.1161/01.CIR.94.11.2749
Moreyra, 1995, Coronary angioplasty in unstable angina: contemporary experience, Can J Cardiol, 11, 385
Stammen, 1992, Immediate and follow-up results of the conservative coronary angioplasty strategy for unstable angina pectoris, Am J Cardiol, 69, 1533, 10.1016/0002-9149(92)90698-X
Perry, 1988, Coronary angioplasty in unstable angina and stable angina: a comparison of success and complications, Br Heart J, 60, 367, 10.1136/hrt.60.5.367
Safian, 1987, Usefulness of percutaneous transluminal coronary angioplasty for unstable angina pectoris after non-Q-wave acute myocardial infarction, Am J Cardiol, 59, 263, 10.1016/0002-9149(87)90796-X
Kamp, 1989, Short-, medium-, and long-term follow-up after percutaneous transluminal coronary angioplasty for stable and unstable angina pectoris, Am Heart J, 117, 991, 10.1016/0002-8703(89)90851-X
Cairns, 1996, Unstable angina—report from a Canadian expert roundtable, Can J Cardiol, 12, 1279
Khan, 1998, Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty?, J Am Coll Cardiol, 31, 31, 10.1016/S0735-1097(97)00423-3
Malosky, 1994, Comparison of results of intracoronary stenting in patients with unstable vs. stable angina, Cathet Cardiovasc Diagn, 31, 95, 10.1002/ccd.1810310202
Marzocchi, 1997, Results of coronary stenting for unstable versus stable angina pectoris, Am J Cardiol, 79, 1314, 10.1016/S0002-9149(97)00131-8
Schuhlen, 1998, Intracoronary stenting and risk for major adverse cardiac events during the first month, Circulation, 98, 104, 10.1161/01.CIR.98.2.104
Deleted in proof.
Kandzari, 2005, Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes, Am J Cardiol, 96, 750, 10.1016/j.amjcard.2005.05.015
Hochman, 2005, Design and methodology of the Occluded Artery Trial (OAT), Am Heart J, 150, 627, 10.1016/j.ahj.2005.07.002
Hochman, 2006, Coronary intervention for persistent occlusion after myocardial infarction, N Engl J Med, 355, 2395, 10.1056/NEJMoa066139
Topol, 1994, Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months, Lancet, 343, 881, 10.1016/S0140-6736(94)90007-8
Topol, 1997, Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention, JAMA, 278, 479, 10.1001/jama.1997.03550060055036
Kong, 1998, Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease, Circulation, 98, 2829, 10.1161/01.CIR.98.25.2829
Kastrati, 2004, A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel, N Engl J Med, 350, 232, 10.1056/NEJMoa031859
Pocock, 1995, Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery, Lancet, 346, 1184, 10.1016/S0140-6736(95)92897-9
1997, Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease: a multicenter randomized trial, JAMA, 277, 715, 10.1001/jama.1997.03540330037032
1996, Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease, N Engl J Med, 335, 217, 10.1056/NEJM199607253350401
2000, Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status, J Am Coll Cardiol, 35, 1122, 10.1016/S0735-1097(00)00533-7
1995, First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation), Lancet, 346, 1179, 10.1016/S0140-6736(95)92896-0
Weintraub, 1998, Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease, J Am Coll Cardiol, 31, 10, 10.1016/S0735-1097(97)00441-5
Hannan, 2005, Long-term outcomes of coronary-artery bypass grafting versus stent implantation, N Engl J Med, 352, 2174, 10.1056/NEJMoa040316
Detre, 1999, Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI), Circulation, 99, 633, 10.1161/01.CIR.99.5.633
Bhatt, 2000, Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes, JAMA, 284, 1549, 10.1001/jama.284.12.1549
Ferguson, 2002, A decade of change—risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990–1999: a report from the STS National Database Committee and the Duke Clinical Research Institute, Ann Thorac Surg, 73, 480, 10.1016/S0003-4975(01)03339-2
Morrison, 2001, Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial, J Am Coll Cardiol, 38, 143, 10.1016/S0735-1097(01)01366-3
Mercado, 2005, One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a metaanalysis of individual patient data from randomized clinical trials, J Thorac Cardiovasc Surg, 130, 512, 10.1016/j.jtcvs.2004.12.049
Serruys, 2001, Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease, N Engl J Med, 344, 1117, 10.1056/NEJM200104123441502
Rodriguez, 2001, Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results, J Am Coll Cardiol, 37, 51, 10.1016/S0735-1097(00)01052-4
2002, Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial, Lancet, 360, 965, 10.1016/S0140-6736(02)11078-6
Hueb, 2004, The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease:one-year results, J Am Coll Cardiol, 43, 1743, 10.1016/j.jacc.2003.08.065
Legrand, 2004, Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease, Circulation, 109, 1114, 10.1161/01.CIR.0000118504.61212.4B
Khan, 2004, A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery, N Engl J Med, 350, 21, 10.1056/NEJMoa031282
Camenzind
Ferraris, 2005, The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary), Ann Thorac Surg, 79, 1454, 10.1016/j.athoracsur.2005.01.008
1993, Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial, Lancet, 341, 573, 10.1016/0140-6736(93)90348-K
Yusuf, 1994, Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration, Lancet, 344, 563, 10.1016/S0140-6736(94)91963-1
1984, Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina, N Engl J Med, 311, 1333, 10.1056/NEJM198411223112102
1983, Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery, Circulation, 98, 939
De Feyter, 1986, Coronary angioplasty of the unstable angina related vessel in patients with multivessel disease, Eur Heart J, 7, 460, 10.1093/oxfordjournals.eurheartj.a062092
Mock, 1988, Comparison of effects of medical and surgical therapy on survival in severe angina pectoris and two-vessel coronary artery disease with and without left ventricular dysfunction: a Coronary Artery Surgery Study Registry Study, Am J Cardiol, 61, 1198, 10.1016/0002-9149(88)91154-X
Gluckman, 2005, A simplified approach to the management of non-ST-segment elevation acute coronary syndromes, JAMA, 293, 349, 10.1001/jama.293.3.349
Beckie, 1989, A supportive-educative telephone program: impact on knowledge and anxiety after coronary artery bypass graft surgery, Heart Lung, 18, 46
2006, State-Specific Prevalence of Obesity Among Adults—United States, 2005, MMWR, 55, 985
Mukherjee, 2004, Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes, Circulation, 109, 745, 10.1161/01.CIR.0000112577.69066.CB
Mukherjee, 2005, Impact of combination evidence based medical treatment in patients with acute coronary syndromes in various TIMI risk groups, Heart, 91, 381, 10.1136/hrt.2004.036459
Fox, 2003, Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study), Lancet, 362, 782, 10.1016/S0140-6736(03)14286-9
Braunwald, 2004, Angiotensinconverting-enzyme inhibition in stable coronary artery disease, N Engl J Med, 351, 2058, 10.1056/NEJMoa042739
Dagenais, 2006, Angiotensinconverting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials, Lancet, 368, 581, 10.1016/S0140-6736(06)69201-5
Pitt, 2004, ACE inhibitors for patients with vascular disease without left ventricular dysfunction—may they rest in PEACE?, N Engl J Med, 351, 2115, 10.1056/NEJMe048255
1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Lancet, 344, 1383
1998, Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels, N Engl J Med, 339, 1349, 10.1056/NEJM199811053391902
Sacks, 1996, The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels, N Engl J Med, 335, 1001, 10.1056/NEJM199610033351401
2002, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial, Lancet, 360, 7, 10.1016/S0140-6736(02)09327-3
de Lemos, 2004, Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial, JAMA, 292, 1307, 10.1001/jama.292.11.1307
Cannon, 2004, Intensive versus moderate lipid lowering with statins after acute coronary syndromes, N Engl J Med, 350, 1495, 10.1056/NEJMoa040583
Nissen, 2006, Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial, JAMA, 295, 1556, 10.1001/jama.295.13.jpc60002
Stenestrand, 2001, Early statin treatment following acute myocardial infarction and 1-year survival, JAMA, 285, 430, 10.1001/jama.285.4.430
Briel, 2006, Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials, JAMA, 295, 2046, 10.1001/jama.295.17.2046
Muhlestein, 2001, Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality, Am J Cardiol, 87, 257, 10.1016/S0002-9149(00)01354-0
Fonarow, 2001, Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP), Am J Cardiol, 87, 819, 10.1016/S0002-9149(00)01519-8
Fonarow, 2001, In-hospital initiation of lipidlowering therapy for patients with coronary heart disease: the time is now, Circulation, 103, 2768, 10.1161/01.CIR.103.23.2768
Rasmussen, 2007, Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction, JAMA, 297, 177, 10.1001/jama.297.2.177
Chobanian, 2003, Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Hypertension, 42, 1206, 10.1161/01.HYP.0000107251.49515.c2
Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512
Bantle, 2006, Nutrition recommendations and interventions for diabetes—2006: a position statement of the American Diabetes Association, Diabetes Care, 29, 2140, 10.2337/dc06-9914
2006, Summary of revisions for the 2006 Clinical Practice Recommendations, Diabetes Care, 29, S3
Daly, 1983, Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction, Br Med J (Clin Res Ed), 287, 324, 10.1136/bmj.287.6388.324
1996
Thompson, 2005, Exercise prescription and proscription for patients with coronary artery disease, Circulation, 112, 2354, 10.1161/CIRCULATIONAHA.104.502591
Gondoni, 2006, A simple tool to predict exercise capacity of obese patients with ischaemic heart disease, Heart, 92, 899, 10.1136/hrt.2005.064758
Rankin, 1996, A specific activity questionnaire to measure the functional capacity of cardiac patients, Am J Cardiol, 77, 1220, 10.1016/S0002-9149(97)89157-6
Hlatky, 1989, A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index), Am J Cardiol, 64, 651, 10.1016/0002-9149(89)90496-7
Morris, 1993, Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men, J Am Coll Cardiol, 22, 175, 10.1016/0735-1097(93)90832-L
Wenger, 1995, Cardiac rehabilitation as secondary prevention, Clin Pract Guidel Quick Ref Guide Clin, 1
Fletcher, 1996, Statement on exercise:benefits and recommendations for physical activity programs for all Americans, Circulation, 94, 857, 10.1161/01.CIR.94.4.857
Flaker, 1999, Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations, J Am Coll Cardiol, 34, 106, 10.1016/S0735-1097(99)00145-X
Antman, 2007, Use of nonsteroidal antiinflammatory drugs, Circulation, 115, 1634, 10.1161/CIRCULATIONAHA.106.181424
Hulley, 1998, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women, JAMA, 280, 605, 10.1001/jama.280.7.605
Manson, 2003, Estrogen plus progestin and the risk of coronary heart disease, N Engl J Med, 349, 523, 10.1056/NEJMoa030808
Wassertheil-Smoller, 2004, Association between cardiovascular outcomes and antihypertensive drug treatment in older women, JAMA, 292, 2849, 10.1001/jama.292.23.2849
Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321
Stampfer, 1992, A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians, JAMA, 268, 877, 10.1001/jama.1992.03490070059042
Sullivan, 1994, Chest pain in women: clinical, investigative, and prognostic features, BMJ, 308, 883, 10.1136/bmj.308.6933.883
Lonn, 2006, Homocysteine lowering with folic acid and B vitamins in vascular disease, N Engl J Med, 354, 1567, 10.1056/NEJMoa060900
Bonaa, 2006, Homocysteine lowering and cardiovascular events after acute myocardial infarction, N Engl J Med, 354, 1578, 10.1056/NEJMoa055227
Bjelakovic, 2007, Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systemic review and meta-analysis, JAMA, 297, 842, 10.1001/jama.297.8.842
Schechtman, 1989, Risk stratification of patients with non-Q wave myocardial infarction: the critical role of ST segment depression, Circulation, 80, 1148, 10.1161/01.CIR.80.5.1148
Stubbs, 1996, Prospective study of the role of cardiac troponin T in patients admitted with unstable angina, BMJ, 313, 262, 10.1136/bmj.313.7052.262
Newby, 1998, Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes, Circulation, 98, 1853, 10.1161/01.CIR.98.18.1853
van Domburg, 1998, Unstable angina: good long-term outcome after a complicated early course, J Am Coll Cardiol, 31, 1534, 10.1016/S0735-1097(98)00140-5
Frasure-Smith, 1995, Depression and 18-month prognosis after myocardial infarction, Circulation, 91, 999, 10.1161/01.CIR.91.4.999
Glassman, 2002, Sertraline treatment of major depression in patients with acute MI or unstable angina, JAMA, 288, 701, 10.1001/jama.288.6.701
Carney, 2004, Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease ENRICHD) study, Psychosom Med, 66, 466, 10.1097/01.psy.0000133362.75075.a6
Lesperance, 2007, Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial, JAMA, 297, 367, 10.1001/jama.297.4.367
Demyttenaere, 2003, Risk factors and predictors of compliance in depression, Eur Neuropsychopharmacol, 13, S69, 10.1016/S0924-977X(03)00095-6
Stromberg, 1999, Factorsinfluencing patient compliance with therapeutic regimens in chronic heart failure: a critical incident technique analysis, Heart Lung, 18, 334, 10.1053/hl.1999.v28.a99538
Rosenstock, 1988, Adoption and maintenance of lifestyle modifications, Am J Prev Med, 4, 349, 10.1016/S0749-3797(18)31145-0
Balady, 2000, Core components of cardiac rehabilitation/secondary prevention programs: a statement for healthcare professionals from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation Writing Group, Circulation, 102, 1069, 10.1161/01.CIR.102.9.1069
King, 2005, Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: a scientific statement from the American Heart Association/American Association for Cardiovascular and Pulmonary Rehabilitation, Circulation, 112, 3354, 10.1161/CIRCULATIONAHA.105.170333
Feigenbaum, 1988
Jolliffe, 2001, Exercise-based rehabilitation for coronary heart disease, Cochrane Database Syst Rev, 10.1002/14651858.CD001800
DeBusk, 1994, A case-management system for coronary risk factor modification after acute myocardial infarction, Ann Intern Med, 120, 721, 10.7326/0003-4819-120-9-199405010-00001
Witt, 2004, Cardiac rehabilitation after myocardial infarction in the community, J Am Coll Cardiol, 44, 988, 10.1016/j.jacc.2004.05.062
Oldridge, 1988, Cardiac rehabilitation after myocardial infarction, JAMA, 260, 945, 10.1001/jama.1988.03410070073031
Ades, 1997, Cost-effectiveness of cardiac rehabilitation after myocardial infarction, J Cardiopulm Rehabil, 17, 222, 10.1097/00008483-199707000-00002
Bondestam, 1995, Effects of early rehabilitation on consumption of medical care during the first year after acute myocardial infarction in patients or 65 years of age, Am J Cardiol, 75, 767, 10.1016/S0002-9149(99)80408-1
Barber, 2001, Cardiac rehabilitation for community-based patients with myocardial infarction: factors predicting discharge recommendation and participation, J Clin Epidemiol, 54, 1025, 10.1016/S0895-4356(01)00375-4
Spencer, 2001, Temporal trends and associated factors of inpatient cardiac rehabilitationin patients with acute myocardial infarction: a community-wide perspective, J Cardiopulm Rehabil, 21, 377, 10.1097/00008483-200111000-00006
O'Connor, 1989, An overview of randomized trials of rehabilitation with exercise after myocardial infarction, Circulation, 80, 234, 10.1161/01.CIR.80.2.234
Lavie, 1996, Effects of cardiac rehabilitation and exercise training programs in patients > or = 75 years of age, Am J Cardiol, 78, 675, 10.1016/S0002-9149(96)00393-1
Ziegelstein, 2001, Depression in patients recovering from a myocardial infarction, JAMA, 286, 1621, 10.1001/jama.286.13.1621
Rost, 1992, Return to work after an initial myocardial infarction and subsequent emotional distress, Arch Intern Med, 152, 381, 10.1001/archinte.1992.00400140121026
Froelicher, 1994, Return to work, sexual activity, and other activities after acute myocardial infarction, Heart Lung, 23, 423
Lewin, 1999, Return to work after MI, the roles of depression, health beliefs and rehabilitation, Int J Cardiol, 72, 49, 10.1016/S0167-5273(99)00174-6
Grines, 1998, Safety and costeffectiveness of early dischrge after primary angioplasty in low risk patients with acute myocardial infarction, J Am Coll Cardiol, 31, 967, 10.1016/S0735-1097(98)00031-X
Petrie, 2002, Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial, Psychosom Med, 64, 580, 10.1097/00006842-200207000-00007
Ostir, 2002, Differential effects of premorbid physical and emotional health on recovery from acute events, J Am Geriatr Soc, 50, 713, 10.1046/j.1532-5415.2002.50167.x
Sansone, 2002, Analysis of FIM instrument scores for patients admitted to an inpatient cardiac rehabilitation program, Arch Phys Med Rehabil, 83, 506, 10.1053/apmr.2002.31183
Froom, 1999, Referral to occupational medicine clinics and resumption of employment after myocardial infarction, J Occup Environ Med, 41, 943, 10.1097/00043764-199911000-00004
Boudrez, 2000, Recent findings on return to work after an acute myocardial infarction or coronary artery bypass grafting, Acta Cardiol, 55, 341, 10.2143/AC.55.6.2005765
Mittag, 2001, Return to work after myocardial infarction/coronary artery bypass grafting: patients' and physicians' initial viewpoints and outcome 12months later, Soc Sci Med, 52, 1441, 10.1016/S0277-9536(00)00250-1
Kavanagh, 1998, On-site evaluation of bus drivers with coronary heart disease, J Cardiopulm Rehabil, 18, 209, 10.1097/00008483-199805000-00004
Covinsky, 2000, Differences in patient-reported processes and outcomes between men and women with myocardial infarction, J Gen Intern Med, 15, 169, 10.1046/j.1525-1497.2000.01269.x
Antman, 2000, The length of the hospital stay after myocardial infarction, N Engl J Med, 342, 808, 10.1056/NEJM200003163421109
Haskell, 1978, Rehabilitation of the coronary patient, 147
Usher, 1986, Physician influences on timing of return to work after myocardial infarction, Circulation, 74
Petrucelli E, Manilowski M. Status of Medical Review in Drier Liscensing: Policies, Programs and Standards. Springfield, VA:National Highway Traffic Safety Administration, US Dept of Transportation; 992. DOT HS 807 892.
Code of Federal Regulation 14CFR 121. Pg 427, Section 25.841. Published by the Office of Federal Register. January 1, 2002.
Code of Federal Regulation 14 CFR 121. Appendix A:555-7. Published by the Office of the Federal Register. January 1, 2002.
Deleted in proof.
Cannon, 1992, Pathophysiological dilemma of syndrome X, Circulation, 85, 883, 10.1161/01.CIR.85.3.883
DeSanctis, 1993, Clinical manifestations of coronary artery disease:chest pain in women, 67
Shaw, 2006, The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study, J Am Coll Cardiol, 47, S36, 10.1016/j.jacc.2005.03.080
Stone, 1996, Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: the TIMI III registry, JAMA, 275, 1104, 10.1001/jama.1996.03530380046030
Keelan, 1997, Comparison of immediate and long-term outcome of coronary angioplasty performed for unstable angina and rest pain in men and women, Mayo Clin Proc, 72, 5, 10.4065/72.1.5
Robertson, 1997, Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry, Am J Cardiol, 80, 26K, 10.1016/S0002-9149(97)00762-5
DeVon, 2002, Symptoms of acute coronary syndromes: arethere gender differences?, Heart Lung, 31, 235, 10.1067/mhl.2002.126105
Califf, 2002, Underuse of aspirin in a referral population with documented coronary artery disease, Am J Cardiol, 89, 653, 10.1016/S0002-9149(01)02335-9
Shaw, 1994, Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease, Ann Intern Med, 120, 559, 10.7326/0003-4819-120-7-199404010-00005
Lansky, 2005, Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association, Circulation, 111, 940, 10.1161/01.CIR.0000155337.50423.C9
Alexander, 2005, Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes, JAMA, 294, 3108, 10.1001/jama.294.24.3108
Cowley, 1985, Sex differences in early and long-term results of coronary ngioplasty in the NHLBI PTCA Registry, Circulation, 71, 90, 10.1161/01.CIR.71.1.90
Kelsey, 1993, Results of percutaneous transluminal coronary angioplasty in women: 1985–1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry, Circulation, 87, 720, 10.1161/01.CIR.87.3.720
Bell, 1993, The changing in-hospital mortality of women undergoing percutaneous transluminal coronary angioplasty, JAMA, 269, 2091, 10.1001/jama.1993.03500160061032
Fisher, 1982, Association of sex, physical size, and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS), J Thorac Cardiovasc Surg, 84, 334, 10.1016/S0022-5223(19)39000-2
Loop, 1983, Coronary artery surgery in women compared with men: analyses of risks and long-term results, J Am Coll Cardiol, 1, 383, 10.1016/S0735-1097(83)80064-3
Arnold, 1994, Genderdifferences for coronary angioplasty, Am J Cardiol, 74, 18, 10.1016/0002-9149(94)90484-7
Weintraub, 1994, Percutaneous transluminal coronary angioplasty in women compared with men, J Am Coll Cardiol, 24, 81, 10.1016/0735-1097(94)90545-2
Welty, 1994, Similar results of percutaneous transluminal coronary angioplasty for women and men with postmyocardial infarction ischemia, J Am Coll Cardiol, 23, 35, 10.1016/0735-1097(94)90499-5
Eysmann, 1993, Coronary heart disease: therapeutic principles, 43
Jacobs, 1997, Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993–94 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry), Am J Cardiol, 80, 979, 10.1016/S0002-9149(97)00588-2
Mikhail, 2006, Coronary revascularisation in women, Heart, 92, iii19
Lansky, 2004, Outcomes of percutaneous and surgical revascularization in women, Prog Cardiovasc Dis, 46, 305, 10.1016/j.pcad.2003.08.004
Humphries, 2007, Significant improvement in short-term mortality in women undergoing coronary artery bypass surgery (1991 to 2004), J Am Coll Cardiol, 49, 1552, 10.1016/j.jacc.2006.08.068
Jacobs, 1998, Better outcome for women compared with men undergoing coronary revascularization: a report from the Bypass Angioplasty Revascularization Investigation (BARI), Circulation, 98, 1279, 10.1161/01.CIR.98.13.1279
Fox, 2002, Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial, Lancet, 360, 743, 10.1016/S0140-6736(02)09894-X
Cannon, 2001, Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with glycoprotein I. Ib/I.I. Ia inhibitor tirofiban, N Engl J Med, 344, 1879, 10.1056/NEJM200106213442501
Morise, 1995, Comparison of the sensitivity and specificity of exercise electrocardiography in biased and unbiased populations of men and women, Am Heart J, 130, 741, 10.1016/0002-8703(95)90072-1
Williams, 1994, Comparison of exercise echocardiography with an exercise score to diagnose coronary artery disease in women, Am J Cardiol, 74, 435, 10.1016/0002-9149(94)90898-2
Robert, 1991, Logistic discriminant analysis improves diagnostic accuracy of exercise testing for coronary artery disease in women, Circulation, 83, 1202, 10.1161/01.CIR.83.4.1202
Shaw, 2003, Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients, J Nucl Med, 44, 134
Alexander, 1998, Value of exercise treadmill testing in women, J Am Coll Cardiol, 32, 1657, 10.1016/S0735-1097(98)00451-3
Lewis, 1999, Dobutamine stress echocardiography in women with chest pain: pilot phase data from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE), J Am Coll Cardiol, 33, 1462, 10.1016/S0735-1097(99)00076-5
Shaw, 2006, Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies, J Am Coll Cardiol, 47, S4, 10.1016/j.jacc.2005.01.072
Gierach, 2006, Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) study, J Am Coll Cardiol, 47, S50, 10.1016/j.jacc.2005.02.099
Handberg, 2006, Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) study, J Am Coll Cardiol, 47, S44, 10.1016/j.jacc.2005.10.023
Pepine, 2006, Some thoughts on the vasculopathy of women with ischemic heart disease, J Am Coll Cardiol, 47, S30, 10.1016/j.jacc.2005.09.023
Lerman, 2006, Women and cardiovascular heart disease: clinical implications from the Women's Ischemia Syndrome Evaluation (WISE) study, J Am Coll Cardiol, 47, S59, 10.1016/j.jacc.2004.10.083
Jacobs, 2006, Women, ischemic heart disease, revascularization, and the gender gap: what are we missing?, J Am Coll Cardiol, 47, S63, 10.1016/j.jacc.2004.12.085
Quyyumi, 2006, Women and ischemic heart disease: pathophysiologic implications from the Women's Ischemia Syndrome Evaluation (WISE) study and future research steps, J Am Coll Cardiol, 47, S66, 10.1016/j.jacc.2004.11.075
Bittl, 1995, Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina, N Engl J Med, 333, 764, 10.1056/NEJM199509213331204
1997, Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI), Circulation, 96, 1761, 10.1161/01.CIR.96.6.1761
Theroux, 1996, Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina, Circulation, 94, 899, 10.1161/01.CIR.94.5.899
Topol, 1994, Recombinant hirudin for unstable angina pectoris: a multicenter, randomized angiographic trial, Circulation, 89, 1557, 10.1161/01.CIR.89.4.1557
Kip, 1996, Coronary angioplasty in diabetic patients: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry, Circulation, 94, 1818, 10.1161/01.CIR.94.8.1818
Stein, 1995, Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty, Circulation, 91, 979, 10.1161/01.CIR.91.4.979
Wilcox, 1991, Prognostic significance of a predischarge exercise test in risk stratification after unstable angina pectoris, J Am Coll Cardiol, 18, 677, 10.1016/0735-1097(91)90789-C
Karlson, 1993, One-year prognosis in patients hospitalized with a history of unstable angina pectoris, Clin Cardiol, 16, 397, 10.1002/clc.4960160506
Fava, 1997, Outcome of unstable angina in patients with diabetes mellitus, Diabet Med, 14, 209, 10.1002/(SICI)1096-9136(199703)14:3<209::AID-DIA324>3.0.CO;2-B
Garcia-Rubira, 1994, Grupo de Estudio del Trifusal en la Angina Inestable, Int J Cardiol, 46, 175
Theroux, 1991, Unstable angina: special considerations in the post-bypass patient, 169
Marchant, 1993, Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes, J Am Coll Cardiol, 22, 1433, 10.1016/0735-1097(93)90554-E
Ambepityia, 1990, Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function, J Am Coll Cardiol, 15, 72, 10.1016/0735-1097(90)90178-R
Zola, 1986, Abnormal cardiac function in diabetic patients with autonomic neuropathy in the absence of ischemic heart disease, J Clin Endocrinol Metab, 63, 208, 10.1210/jcem-63-1-208
Silva, 1995, Unstable angina: a comparison of angioscopic findings between diabetic and nondiabetic patients, Circulation, 92, 1731, 10.1161/01.CIR.92.7.1731
2006, Position statements and ADA statements, Diabetes Care, 29, S75
Bolk, 2001, Impaired glucose metabolism predicts mortality after a myocardial infarction, Int J Cardiol, 79, 207, 10.1016/S0167-5273(01)00422-3
Malmberg, 1997, Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus, BMJ, 314, 1512, 10.1136/bmj.314.7093.1512
Malmberg, 1995, Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year, J Am Coll Cardiol, 26, 57, 10.1016/0735-1097(95)00126-K
Malmberg, 2005, Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity, Eur Heart J, 26, 650, 10.1093/eurheartj/ehi199
Furnary, 1999, Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures, Ann Thorac Surg, 67, 352, 10.1016/S0003-4975(99)00014-4
Furnary, 2003, Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting, J Thorac Cardiovasc Surg, 125, 1007, 10.1067/mtc.2003.181
Golden, 1999, Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes, Diabetes Care, 22, 1408, 10.2337/diacare.22.9.1408
Van den Berghe, 2003, Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control, Crit Care Med, 31, 359, 10.1097/01.CCM.0000045568.12881.10
Capes, 2000, Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview, Lancet, 355, 773, 10.1016/S0140-6736(99)08415-9
Van den Berghe, 2001, Intensive insulin therapy in the critically ill patients, N Engl J Med, 345, 1359, 10.1056/NEJMoa011300
Van den Berghe, 2006, Intensive insulin therapy in the medical ICU, N Engl J Med, 354, 449, 10.1056/NEJMoa052521
Jones, 1991, Coronary bypass surgery: is the operation different today?, J Thorac Cardiovasc Surg, 101, 108, 10.1016/S0022-5223(19)36799-6
King, 2000, Eight year mortality in the Emory Angioplasty vs Surgery Trial (EAST), J Am Coll Cardiol, 35, 1116, 10.1016/S0735-1097(00)00546-5
Kuntz, 1999, Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetespercutaneous transluminal coronary angioplasty dilemma, Circulation, 99, 847, 10.1161/01.CIR.99.7.847
Barsness, 1997, Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty, Circulation, 96, 2551, 10.1161/01.CIR.96.8.2551
Levine, 1997, Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I), Am J Cardiol, 79, 748, 10.1016/S0002-9149(96)00862-4
Malenka, 2005, Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England, Circulation, 112, I371, 10.1161/CIRCULATIONAHA.104.526392
Kleiman, 1998, Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial, Circulation, 97, 1912, 10.1161/01.CIR.97.19.1912
Lincoff, 1997, Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization, J Am Coll Cardiol, 30, 149, 10.1016/S0735-1097(97)00110-1
Topol, 1999, Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting, Lancet, 354, 2019, 10.1016/S0140-6736(99)10018-7
Roffi, 2002, Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up, Circulation, 105, 2730, 10.1161/01.CIR.0000018123.02672.C7
Lambert, 1989, Preoperative and operative predictive variables of late clinical events following saphenous vein coronary artery bypass graft surgery, Can J Cardiol, 5, 87
Waters, 1986, Previous coronary artery bypass grafting as an adverse prognostic factor in unstable angina pectoris, Am J Cardiol, 58, 465, 10.1016/0002-9149(86)90016-0
Grondin, 1984, Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation, Circulation, 70, I208
Neitzel, 1986, Atherosclerosis in aortocoronary bypass grafts: morphologic study and risk factor analysis 6 to 12 years after surgery, Arteriosclerosis, 6, 594, 10.1161/01.ATV.6.6.594
Waller, 1984, Morphologic observations after percutaneous transluminal balloon angioplasty of early and late aortocoronary saphenous vein bypass grafts, J Am Coll Cardiol, 4, 784, 10.1016/S0735-1097(84)80407-6
Walts, 1982, Ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: a mechanism of acute, thrombotic, late graft occlusion, Circulation, 65, 197, 10.1161/01.CIR.65.1.197
Hwang, 1990, Progression of native coronary artery disease at 10 years: insights from a randomized study of medical versus surgical therapy for angina, J Am Coll Cardiol, 16, 1066, 10.1016/0735-1097(90)90533-U
Chen, 1996, Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery, J Am Coll Cardiol, 28, 1493, 10.1016/S0735-1097(96)00344-0
Waters, 1980, Previously undiagnosed variant angina as a cause of chest pain after coronary artery bypass surgery, Circulation, 61, 1159, 10.1161/01.CIR.61.6.1159
Baduini, 1981, Sudden occlusion of a saphenous vein bypass graft relieved by direct injection of nitroglycerin, Cathet Cardiovasc Diagn, 787
Lawrie, 1982, The influence of residual disease after coronary bypass on the 5-year survival rate of 1274 men with coronary artery disease, Circulation, 66, 717, 10.1161/01.CIR.66.4.717
Silva, 1998, Morphologic comparison of atherosclerotic lesions in native coronary arteries and saphenous vein graphs with intracoronary angioscopy in patients with unstable angina, Am Heart J, 136, 156, 10.1016/S0002-8703(98)70196-6
Ritchie, 1977, Thallium-201 myocardial imaging before and after coronary revascularization: assessment of regional myocardial blood flow and graft patency, Circulation, 56, 830, 10.1161/01.CIR.56.5.830
Verani, 1978, Thallium-201 myocardial perfusion scintigrams in the evaluation of aorto-coronary saphenous bypass surgery, J Nucl Med, 19, 765
Carlino, 1999, Prevention of distal embolization during saphenous vein graft lesion angioplasty, Circulation, 99, 3221, 10.1161/01.CIR.99.25.3221
Kleiman, 1996, Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry), Am J Cardiol, 77, 227, 10.1016/S0002-9149(97)89383-6
Savage, 1997, Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts, N Engl J Med, 337, 740, 10.1056/NEJM199709113371103
Alexander, 2005, Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative, J Am Coll Cardiol, 46, 1479, 10.1016/j.jacc.2005.05.084
Nadelmann, 1990, Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: the Bronx Aging Study, Am J Cardiol, 66, 533, 10.1016/0002-9149(90)90477-I
Lakatta, 1997, The aging heart: structure, function, and disease, 1687
Avezum, 2005, Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE), Am Heart J, 149, 67, 10.1016/j.ahj.2004.06.003
Stein, 1997, Principles and practice of pharmacotherapy, 3
Vasilomanolakis, 1985, Geriatric cardiology: when exercise stress testing is justified, Geriatrics, 40, 47
Bhatt, 2004, Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes, JAMA, 292, 2096, 10.1001/jama.292.17.2096
Thompson, 1996, Changing outcome of angioplasty in the elderly, J Am Coll Cardiol, 27, 8, 10.1016/0735-1097(95)00436-X
Thompson, 1993, Predicting early and intermediate-term outcome of coronary angioplasty in the elderly, Circulation, 88, 1579, 10.1161/01.CIR.88.4.1579
Nasser, 1997, Comparison of six-month outcome of coronary artery stenting in patients <65, 65–75, and >75 years of age, Am J Cardiol, 80, 998, 10.1016/S0002-9149(97)00592-4
Bach, 2004, The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes, Ann Intern Med, 141, 186, 10.7326/0003-4819-141-3-200408030-00007
Ivanov, 1998, Fifteen-year trends in risk severity and operative mortality in elderly patients undergoing coronary artery bypass graft surgery, Circulation, 97, 673, 10.1161/01.CIR.97.7.673
Peterson, 1994, Changes in mortality after myocardial revascularization in the elderly: the national Medicare experience, Ann Intern Med, 121, 919, 10.7326/0003-4819-121-12-199412150-00003
Freeman, 1991, Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up, J Am Coll Cardiol, 18, 29, 10.1016/S0735-1097(10)80212-8
Kaul, 1994, Angioplasty versus coronary artery bypass in octogenarians, Ann Thorac Surg, 58, 1419, 10.1016/0003-4975(94)91927-5
Ko, 1992, Survival analysis of octogenarian patients with coronary artery disease managed by elective coronary artery bypass surgery versus conventional medical treatment, Circulation, 86, II191
Glower, 1992, Performance status and outcome after coronary artery bypass grafting in persons aged 80 to 93 years, Am J Cardiol, 70, 567, 10.1016/0002-9149(92)90192-2
Bridges, 2003, Cardiac surgery in nonagenarians and centenarians, J Am Coll Surg, 197, 347, 10.1016/S1072-7515(03)00384-3
Anavekar, 2004, Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction, N Engl J Med, 351, 1285, 10.1056/NEJMoa041365
Go, 2004, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization, N Engl J Med, 351, 1296, 10.1056/NEJMoa041031
Weiner, 2004, Kidney disease as a risk factor for recurrent cardiovascular disease and mortality, Am J Kidney Dis, 44, 198, 10.1053/j.ajkd.2004.04.024
Jo, 2006, Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography:the RECOVER study: a randomized controlled trial, J Am Coll Cardiol, 48, 924, 10.1016/j.jacc.2006.06.047
McCullough, 2006, A metaanalysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media, J Am Coll Cardiol, 48, 692, 10.1016/j.jacc.2006.02.073
Isner, 1991, Cardiovascular complications of cocaine, Curr Probl Cardiol, 16, 89, 10.1016/0146-2806(91)90013-Z
Kloner, 1992, The effects of acute and chronic cocaine use on the heart, Circulation, 85, 407, 10.1161/01.CIR.85.2.407
Pitts, 1997, Cocaine-induced myocardial ischemia and infarction: pathophysiology, recognition, and management, Prog Cardiovasc Dis, 40, 65, 10.1016/S0033-0620(97)80023-0
Lange, 1990, Cocaine-induced myocardial ischemia, Cardio, 40, 74
Loper, 1989, Clinical toxicology of cocaine, Med Toxicol Adverse Drug Exp, 4, 174, 10.1007/BF03259995
Flores, 1990, Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease:enhanced vasoconstriction at sites of significant stenoses, J Am Coll Cardiol, 16, 74, 10.1016/0735-1097(90)90459-3
Lange, 1989, Cocaine-induced coronary-artery vasoconstriction, N Engl J Med, 321, 1557, 10.1056/NEJM198912073212301
Zimmerman, 1987, Recurrent myocardial infarction associated with cocaine abuse in a young man with normal coronary arteries: evidence for coronary artery spasm culminating in thrombosis, J Am Coll Cardiol, 9, 964, 10.1016/S0735-1097(87)80256-5
Bedotto, 1988, Cocaine and cardiovascular function in dogs: effects on heart and peripheral circulation, J Am Coll Cardiol, 11, 1337, 10.1016/0735-1097(88)90301-4
Brogan, 1991, Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin, J Am Coll Cardiol, 18, 581, 10.1016/0735-1097(91)90617-I
Nademanee, 1989, Myocardial ischemia during cocaine withdrawal, Ann Intern Med, 111, 876, 10.7326/0003-4819-111-11-876
Vitullo, 1989, Cocaine-induced small vessel spasm in isolated rat hearts, Am J Pathol, 135, 85
Togna, 1985, Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment, Haemostasis, 15, 100
Chokshi, 1989, Cocaine and cardiovascular diseases:leading edge, Cardiol, 3, 1
Stenberg, 1989, Simultaneous acute thrombosis of two major coronary arteries following intravenous cocaine use, Arch Pathol Lab Med, 113, 521
Hollander, 1998, Assessment of cocaine use in patients with chest pain syndromes, Arch Intern Med, 158, 62, 10.1001/archinte.158.1.62
Gitter, 1991, Cocaine and chest pain: clinical features and outcome of patients hospitalized to rule out myocardial infarction, Ann Intern Med, 115, 277, 10.7326/0003-4819-115-4-277
Dressler, 1990, Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts, Am J Cardiol, 65, 303, 10.1016/0002-9149(90)90292-9
Virmani, 1988, Cardiovascular effects of cocaine: an autopsy study of 40 patients, Am Heart J, 115, 1068, 10.1016/0002-8703(88)90078-6
Rashid, 1996, Cocaine-induced aortic dissection, Am Heart J, 132, 1301, 10.1016/S0002-8703(96)90486-X
Willens, 1994, Cardiovascular manifestations of cocaine abuse: a case of recurrent dilated cardiomyopathy, Chest, 106, 594, 10.1378/chest.106.2.594
Chokshi, 1989, Reversible cardiomyopathy associated with cocaine intoxication, Ann Intern Med, 111, 1039, 10.7326/0003-4819-111-12-1039
Yao, 1997, Successful intracoronary thrombolysis in cocaineassociated acute myocardial infarction, Cathet Cardiovasc Diagn, 42, 294, 10.1002/(SICI)1097-0304(199711)42:3<294::AID-CCD15>3.0.CO;2-M
Hollander, 1995, The management of cocaine-associated myocardial ischemia, N Engl J Med, 333, 1267, 10.1056/NEJM199511093331907
Tokarski, 1990, An evaluation of cocaine-induced chest pain, Ann Emerg Med, 19, 1088, 10.1016/S0196-0644(05)81509-4
Hollander, 1994, Prospective multicenter evaluation of cocaine-associated chest pain, Acad Emerg Med, 1, 330, 10.1111/j.1553-2712.1994.tb02639.x
Weber, 2003, Validation of a brief observation period for patients with cocaineassociated chest pain, N Engl J Med, 348, 510, 10.1056/NEJMoa022206
Lange, 1990, Potentiation of cocaineinduced coronary vasoconstriction by beta-adrenergic blockade, Ann Intern Med, 112, 897, 10.7326/0003-4819-112-12-897
Boehrer, 1993, Influence of labetalol on cocaine-induced coronary vasoconstriction in humans, Am J Med, 94, 608, 10.1016/0002-9343(93)90212-8
Furst, 1990, Myocardial infarction after inhalation of methamphetamine, N Engl J Med, 323, 1147, 10.1056/NEJM199010183231617
Turnipseed, 2003, Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use, J Emerg Med, 24, 369, 10.1016/S0736-4679(03)00031-3
Wijetunga, 2004, Acute coronary syndrome and crystal methamphetamine use: a case series, Hawaii Med J, 63, 8
Watts, 2006, Methamphetamine-induced myocardial infarction with elevated troponin I, Am J Emerg Med, 24, 132, 10.1016/j.ajem.2005.08.005
Ozaki, 1995, Fluctuation of spastic location in patients with vasospastic angina: a quantitative angiographic study, J Am Coll Cardiol, 26, 1606, 10.1016/0735-1097(95)00398-3
Yamagishi, 1994, Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments, J Am Coll Cardiol, 23, 352, 10.1016/0735-1097(94)90419-7
Maseri, 1978, “Variant” angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia, Am J Cardiol, 42, 1019, 10.1016/0002-9149(78)90691-4
Walling, 1987, Long-term prognosis of patients with variant angina, Circulation, 76, 990, 10.1161/01.CIR.76.5.990
Rovai, 1997, Organic coronary stenosis in Prinzmetal's variant angina, J Cardiol, 30, 299
Previtali, 1989, Hyperventilation and ergonovine tests in Prinzmetal's variant angina pectoris in men, Am J Cardiol, 63, 17, 10.1016/0002-9149(89)91068-0
Matsuda, 1983, Coronary arteriography and left ventriculography during spontaneous and exercise-induced ST segment elevation in patients with variant angina, Am Heart J, 106, 509, 10.1016/0002-8703(83)90694-4
Raizner, 1980, Provocation of coronary artery spasm by the cold pressor test, Circulation, 62, 925, 10.1161/01.CIR.62.5.925
Ogawa, 1989, Circadian variation of plasma fibrinopeptide A level in patients with variant angina, Circulation, 80, 1617, 10.1161/01.CIR.80.6.1617
Nobuyoshi, 1992, Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant, Am Heart J, 124, 32, 10.1016/0002-8703(92)90917-K
Sugiishi, 1993, Cigarette smoking is a major risk factor for coronary spasm, Circulation, 87, 76, 10.1161/01.CIR.87.1.76
Miller, 1982, Clinical characteristics associated with sudden death in patients with variant angina, Circulation, 66, 588, 10.1161/01.CIR.66.3.588
Fukai, 1993, Role of coronary vasospasm in the pathogenesis of myocardial infarction: study in patients with no significant coronary stenosis, Am Heart J, 126, 1305, 10.1016/0002-8703(93)90527-G
MacAlpin, 1993, Cardiac arrest and sudden unexpected death in variant angina: complications of coronary spasm that can occur in the absence of severe organic coronary stenosis, Am Heart J, 125, 1011, 10.1016/0002-8703(93)90108-L
Willerson, 1986, Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes, J Am Coll Cardiol, 8, 245, 10.1016/S0735-1097(86)80121-8
Kugiyama, 1996, Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina, Circulation, 94, 266, 10.1161/01.CIR.94.3.266
Yasue, 1976, Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: documentation by coronary arteriography, Am Heart J, 91, 148, 10.1016/S0002-8703(76)80568-6
Shephard, 1991, Endothelium derived vasoactive factors: I endothelium-dependent relaxation, Hypertension, 18, 76
Yasue, 1986, Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm, Circulation, 74, 955, 10.1161/01.CIR.74.5.955
Katsumata, 1997, Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1beta, Circulation, 96, 4357, 10.1161/01.CIR.96.12.4357
Nakao, 1997, Hyperventilation as a specific test for diagnosis of coronary artery spasm, Am J Cardiol, 80, 545, 10.1016/S0002-9149(97)00419-0
Pepine, 1996, Ergonovine echocardiography for coronary spasm: facts and wishful thinking, J Am Coll Cardiol, 27, 1162, 10.1016/0735-1097(96)00015-0
Opie, 1996, Calcium channel antagonists in the management of anginal syndromes: changing concepts in relation to the role of coronary vasospasm, Prog Cardiovasc Dis, 38, 291, 10.1016/S0033-0620(96)80015-6
Chahine, 1993, Randomized placebocontrolled trial of amlodipine in vasospastic angina, J Am Coll Cardiol, 21, 1365, 10.1016/0735-1097(93)90310-W
Lombardi, 1993, Efficacy of isosorbide-5–mononitrate versus nifedipine in preventing spontaneous and ergonovine-induced myocardial ische aemia: a double-blind, placebo-controlled study, Eur Heart J, 14, 845, 10.1093/eurheartj/14.6.845
Yasue, 1988, Long-term prognosis for patients with variant angina and influential factors, Circulation, 78, 1, 10.1161/01.CIR.78.1.1
Kaski, 2004, Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X), Circulation, 109, 568, 10.1161/01.CIR.0000116601.58103.62
Rosen, 1994, Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X, Circulation, 90, 50, 10.1161/01.CIR.90.1.50
Bugiardini, 2005, Angina with “normal” coronary arteries: a changing philosophy, JAMA, 293, 477, 10.1001/jama.293.4.477
Kaski, 1995, Cardiac syndrome X: clinical characteristics and left ventricular function: long-term follow-up study, J Am Coll Cardiol, 25, 807, 10.1016/0735-1097(94)00507-M
Mohri, 1998, Angina pectoris caused by coronary microvascular spasm, Lancet, 351, 1165, 10.1016/S0140-6736(97)07329-7
Camici, 1991, Coronary hemodynamics and myocardial metabolism in patients with syndrome X:response to pacing stress, J Am Coll Cardiol, 17, 1461, 10.1016/0735-1097(91)90632-J
Kaski, 1998, Differential plasma endothelin levels in subgroups of patients with angina and angiographically normal coronary arteries, Am Heart J, 136, 412, 10.1016/S0002-8703(98)70214-5
Panting, 2002, Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging, N Engl J Med, 346, 1948, 10.1056/NEJMoa012369
Buchthal, 2000, Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms, N Engl J Med, 342, 829, 10.1056/NEJM200003233421201
Anselmi, 1997, Comparison of left ventricular function and volumes during ransesophageal atrial pacing combined with two-dimensional echocardiography in patients with syndrome X, atherosclerotic coronary artery disease, and normal subjects, Am J Cardiol, 80, 1261, 10.1016/S0002-9149(97)00662-0
Kemp, 1986, Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study, J Am Coll Cardiol, 7, 479, 10.1016/S0735-1097(86)80456-9
Opherk, 1989, Four-year follow-up study in patients with angina pectoris and normal coronary arteriograms (“syndrome X”), Circulation, 80, 1610, 10.1161/01.CIR.80.6.1610
Cannon, 1985, Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve, Am J Cardiol, 56, 242, 10.1016/0002-9149(85)90842-2
Bugiardini, 1989, Comparison of verapamil versus propranolol therapy in syndrome X, Am J Cardiol, 63, 286, 10.1016/0002-9149(89)90332-9
Maseri, 1995
Galassi, 1989, Lack of evidence for alpha-adrenergic receptor-mediated mechanisms in the genesis of ischemia in syndrome X, Am J Cardiol, 64, 264, 10.1016/0002-9149(89)90517-1
Cannon, 1994, Imipramine in patients with chest pain despite normal coronary angiograms, N Engl J Med, 330, 1411, 10.1056/NEJM199405193302003
Chauhan, 1994, Is coronary flow reserve in response to papaverine really normal in syndrome X?, Circulation, 89, 1998, 10.1161/01.CIR.89.5.1998
Eliasson, 1993, Spinal cord stimulation in angina pectoris with normal coronary arteriograms, Coron Artery Dis, 4, 819, 10.1097/00019501-199309000-00009
Roque, 1998, Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms, J Am Coll Cardiol, 31, 139, 10.1016/S0735-1097(97)00436-1
Rosano, 1996, 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X, J Am Coll Cardiol, 28, 1500, 10.1016/S0735-1097(96)00348-8
Kayikcioglu, 2003, Benefits of statin treatment in cardiac syndrome-X1, Eur Heart J, 24, 1999, 10.1016/S0195-668X(03)00478-0
Eriksson, 2000, Physical training in Syndrome X: physical training counteracts deconditioning and pain in Syndrome X, J Am Coll Cardiol, 36, 1619, 10.1016/S0735-1097(00)00931-1
Mayou, 1997, A controlled trial of cognitive behavioural therapy for non-cardiac chest pain, Psychol Med, 27, 1021, 10.1017/S0033291797005254
Sharkey, 2005, Acute and reversible cardiomyopathy provoked by stress in women from the United States, Circulation, 111, 472, 10.1161/01.CIR.0000153801.51470.EB
Tsuchihashi, 2001, Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction, J Am Coll Cardiol, 38, 11, 10.1016/S0735-1097(01)01316-X
DeWood, 1980, Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction, N Engl J Med, 303, 897, 10.1056/NEJM198010163031601
Rentrop, 1981, Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris, Circulation, 63, 307, 10.1161/01.CIR.63.2.307
Ganz, 1981, Intracoronary thrombolysis in evolving myocardial infarction, Am Heart J, 101, 4, 10.1016/0002-8703(81)90376-8
Anderson, 1983, A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction, N Engl J Med, 308, 1312, 10.1056/NEJM198306023082202
Kennedy, 1983, Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction, N Engl J Med, 309, 1477, 10.1056/NEJM198312153092402
Libby, 1995, Molecular bases of the acute coronary syndromes, Circulation, 91, 2844, 10.1161/01.CIR.91.11.2844
Ross, 1999, Atherosclerosis—an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207
Naghavi, 2003, From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II, Circulation, 108, 1772, 10.1161/01.CIR.0000087481.55887.C9
Naghavi, 2003, From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I, Circulation, 108, 1664, 10.1161/01.CIR.0000087480.94275.97
Furman, 2001, Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, communitywide perspective, J Am Coll Cardiol, 37, 1571, 10.1016/S0735-1097(01)01203-7
Fox, 2007, Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006, JAMA, 297, 1892, 10.1001/jama.297.17.1892
Henry, 2006, ST-segment elevation myocardial infarction: recommendations on triage of patients to heart attack centers: is it time for a national policy for the treatment of ST-segment elevation myocardial infarction?, J Am Coll Cardiol, 47, 1339, 10.1016/j.jacc.2005.05.101
Nallamothu, 2006, Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST-elevation myocardial infarction, Circulation, 113, 1189, 10.1161/CIRCULATIONAHA.105.596346
Jacobs, 2006, Regionalized care for patients with ST-elevation myocardial infarction: it's closer than you think, Circulation, 113, 1159, 10.1161/CIRCULATIONAHA.105.610345
Eisenstein, 2007, Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation, JAMA, 297, 159, 10.1001/jama.297.2.joc60179
Cannon, 2006, Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy, J Am Coll Cardiol, 48, 438, 10.1016/j.jacc.2006.04.070